Detailed Information

Research Field/Keywords for Research Field

• Hematology

Education

• 1986/03, Graduated

Employment Experience

• 1986/05 - 1988/03
• 1988/04 - 1992/05
• 1992/06 - 1994/03
• 1994/04 - 1996/03
• 1994/04 - 1996/03
• 1996/06 - 1997/11
• 1998/04 - 2000/03
• 2000/07 - 2001/06
• 2001/07 - 2002/03
• 2002/04 - 2007/03 Research Associate
• 2007/04 - 2009/03 Assistant Professor
• 2009/04 -  *  Professor, Medicine, Faculty of Medicine, Saga University
• 2009/04 - 2011/03 University Hospital, Faculty of Medicine, Saga University
• 2009/11 -  *  University Hospital, Faculty of Medicine, Saga University
• 2011/04 - 2014/03 University Hospital, Faculty of Medicine, Saga University
• 2012/04 - 2014/03 University Hospital, Faculty of Medicine, Saga University
• 2014/04 -  *  Saga University
• 2014/04 -  *  University Hospital, Faculty of Medicine, Saga University

Field of Specialization

• Hematology, General pharmacology

Research Topics and Results

• Development of a specific and sensitive sandwich enzyme-linked immunosorbent assay for the quantification of dasatinib 2023/08
• Recurrent DLBCL Developing Small Bowel Lesion of Stenotic Type, Report of a Case 2023/07
• どんどん進化する白血病治療 2023/07
• 全てのCML患者の治癒を目指して 2023/06
• Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper Cells: A Case Report 2023/05
• Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study  2023/05
• Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL 2023/04
• Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia  2023/04
• Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia  2023/04
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer 2023/03
• Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia  2023/02
• A 45-Year-Old Woman With Unexplained Iron Deficiency Anemia and No Respiratory Symptoms 2023/01
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer  2023/01
• Effect of Azithromycin on Exacerbations in Asthma Patients with Obesity: Protocol for a Multi-Center, Prospective, Single-Arm Intervention Study  2023/01
• 慢性骨髄性白血病 2023/01
• CMLの行育薬 2023/01
• Type II Cryoglobulinemic Membranoproliferative Glomerulonephritis Caused by Mucosa-associated Lymphoid Tissue Lymphoma 2023
• Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice 2023
• Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study 2023
• Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphoma 2023
• アカデミア創薬に向けて―臨床から 2023
• Simultaneous detection of JAK2, CALR, and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe-Tm method in i-densy IS-5320 2022/12
• Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath 2022/12
• Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia  2022/12
• Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions 2022/12
• Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia  2022/10
• Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma 2022/09
• NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia  2022/08
• Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma  2022/07
• Association of orexin receptor antagonists with falls during hospitalization  2022/06
• THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA 2022/06
• Biological significance of UCK2 in HTLV-1-infected cells in ATL leukemogenesis and acquired resistance to azacitidine 2022/06
• CASE REPORT Immune dysregulation syndrome with CTLA4 mutation showing multiple central nervous system lesions 2022/05
• Correction: HLA Polymorphisms Are Associated With Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia  2022/05
• Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia  2022/05
• Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism  2022/04
• Non-valvular Infective Endocarditis Caused by Sarocladium kiliense in an Immunocompromised Patient with Aplastic Anemia 2022/04
• Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia 2022/03
• Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia  2022/02
• RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia  2022/02
• Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series 2022/02
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test  2022/02
• Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals  2022/01
• Expression level of BTN3A1 on the surface of CD14 + monocytes is a potential predictor of γδ T cell expansion efficiency  2022/01
• Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia  2022/01
• Clonality of HIV-1 and HTLV-1 infected cells in naturally coinfected individuals  2022/01
• Clinical Studies HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide for adult T-cell leukemia 2022
• P-1030.Biological significance of pyrimidine metabolism enzyme UCK2 of HTLV-1-infected cells in ATL leukemogenesis 2022
• E-1006.Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia 2022
• Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial  2021/12
• A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction  2021/12
• Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease 2021/12
• Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial 2021/12
• The development of oral demethylating agent, OR-2100, and its impact on chronic myeloid leukemia 2021/12
• Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors  2021/11
• Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma 2021/11
• Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells 2021/10
• Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience  2021/10
• Serial evaluation of the pharmacokinetics of ponatinib in patients with CML and Ph + ALL  2021/10
• Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death  2021/10
• DNMT1 inhibitor and TKI combination for deeper response and depleting stem cell self-renewal in CML 2021/10
• Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD  2021/09
• Non-valvular Infective Endocarditis Caused by Sarocladium kiliense in an Immunocompromised Patient with Aplastic Anemia: A Case Report  2021/09
• Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman  2021/09
• Severity of constipation related to palonosetron during first-line chemotherapy: a retrospective observational study  2021/08
• Silylation of deoxynucleotide analog yields an orally available drug with anti-leukemia effects  2021/08
• Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute  2021/08
• Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease  2021/08
• Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma  2021/07
• Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab  2021/07
• Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia  2021/06
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies  2021/05
• Evolution of CML treatment  2021/05
• Idiopathic eosinophilic pleurisy: A practical diagnostic approach  2021/05
• Tiotropium/olodaterol reduces sedentary behavior in patients with treatment-na?ve chronic obstructive pulmonary disease 2021/05
• Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan 2021/04
• A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease  2021/04
• Cutting edge therapeutic approaches in CML From Japan Perspective 2021/04
• Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer  2021/03
• Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia 2021/02
• HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia 2021/01
• Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma 2021/01
• Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis 2021/01
• Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome  2021
• Technical Lecture Development and clinical use of an application for management of drug holidays in perioperative periods 2021
• Development of a Competitive Enzyme-Linked Immunosorbent Assay for the Determination of Sunitinib Unaffected by Light-Induced Isomerization  2021
• DNMT1 Inhibitor and TKI Combination for Deeper Response and Depleting Stem Cell Self-renewal in CML 2021
• The clinical outcomes of nivolumab plus ipilimumab combined with platinum-based chemotherapy, single-center, retrospective analysis 2021
• Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease 2020/12
• Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia 2020/12
• Biomarkers for Overweight in Adult-Onset Asthma 2020/10
• A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation 2020/10
• Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report 2020/10
• Development of acquired hemophilia A after treatment of bronchial asthma with benralizumab 2020/10
• First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease 2020/09
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis using the new oral demethylating agent OR-2100 2020/08
• Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells 2020/08
• Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor 2020/08
• Origin of circulating free DNA in patients with lung cancer 2020/07
• J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors 2020/07
• A patient with antibody against low-frequency red blood cell antigen Co^b 2020/07
• Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia 2020/07
• Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors 2020/07
• Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease 2020/07
• Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation 2020/06
• Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case Report 2020/06
• Does patient sex play a role in treatment-free remission in chronic myeloid leukemia? 2020/06
• Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy 2020/06
• Venue of catheter insertion does not significantly impact the event of central line-associated bloodstream infection in patients with haematological diseases 2020/06
• A NEW HYPOMETHYLATING AGENT, OR-2100, RESISTS DEGRADATION BY CYTIDINE DEAMINASE, LEADING TO FAVOURABLE ORAL ABSORBABILITY AND ANT-LEUKAEMIA EFFECTS 2020/06
• HLA POLYMORPHISMS PREDICT TREATMENT-FREE REMISSION FOLLOWING TKI DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA 2020/06
• Development of an application for management of drug holidays in perioperative periods 2020/05
• Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation 2020/05
• Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis 2020/04
• Budget impact analysis of treatment-free remission in nilotinib-treated Japanese chronic myeloid leukemia patients 2020/04
• Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury 2020/04
• Severe infusion reaction, anti-rituximab antibodies and lymphoma. 2020/04
• Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial 2020/03
• Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation 2020/02
• Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation. 2020/02
• A Case of Superficial-Type Gastric Cancer with Metastatic Ovarian Cancer Diagnosed by Exploratory Laparotomy 2020/01
• Clinical impact of the CONUT score in patients with multiple myeloma 2020/01
• Role of cancer immunology in chronic myelogenous leukemia 2020/01
• The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model 2020/01
• The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma 2020
• Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea 2020
• Aplastic anemia in a patient with Cronkhite-Canada syndrome 2020
• The Non-Antibiotic Macrolide EM900 attenuates HDM-induced airway inflammation in Obese Asthma Model 2020
• Clinical characteristics and biomarker for Japanese asthmatic patients with obesity 2020
• POSITIVE RATE OF BLOOD PRODUCTS IN THE IRREGULAR ANTIBODY SCREENING TEST AND THE SIGNIFICANCE OF MINOR CROSSMATCHING IN THE CROSSMATCH TEST 2019/12
• Immunohistochemical localization of afatinib in male rat intestines and skin after its oral administration 2019/11
• Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia. 2019/11
• Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases. 2019/11
• Japan's high-cost medical expense benefit system could be an obstacle to promoting generic imatinib 2019/10
• Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells. 2019/10
• BCR-ABL1- and CBFB-MYH11- positive chronic myeloid leukemiapresenting with primary blast crisis and marrow fibrosis 2019/10
• Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer. 2019/09
• Assessment of tumor volume and density as a measure of the response of advanced hepatocellular carcinoma to sorafenib: Application of automated measurements on computed tomography scans 2019/08
• Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations. 2019/07
• Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy 2019/06
• HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia 2019/06
• Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma 2019/06
• Development status of new therapeutic agents for CML 2019/05
• Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis 2019/05
• Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum 2019/04
• Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial) 2019/04
• A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib 2019/03
• Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenstrom macroglobulinemia essential in MYD88 L265P mutation-positive cases? 2019/03
• C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells 2019/02
• Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib 2019/02
• Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma 2019/02
• Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution. 2019/02
• Evaluation of CML therapy by tyrosine kinase inhibiters and possibility of stop them 2019/01
• Epigenetic abnormalities as a therapeutic target in adult T-cell leukemia-lymphoma 2019/01
• The presence and possible role of virus-host chimeric transcripts in adult T-cell leukemia-lymphoma. 2019
• An effect of novel non-antibiotic macrolide EM900 in HDM-induced airway inflammation mice model 2019
• Acute myeloid leukemia with t(19;21)(q13;q22) transformed from myelodysplastic syndrome with marked eosinophilia. 2019
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.  2018
• Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy. 2018
• Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.  2018
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy 2018
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments. 2018
• Final 3-year results of the Dasatinib Discontinuation Trial in Patients with Chronic Myeloid Leukemia who received dasatinib as a second line treatment 2018
• Prognostic impact of Acute myeloid leukemia with low allelic ratio FLT3-ITD and NPM1 mutation. 2018
• Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia 2018
• Investigation of Appropriate Pre-analytical Procedure for Circulating Free DNA from Liquid Biopsy. 2018
• Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis. 2018
• Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML. 2018
• The Current State of Therapeutic Development for Rare Cancers in Japan, and Proposals for Improvement. 2018
• Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide. 2018
• A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy. 2018
• Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: a rare tumor combination and a potential pitfall of cytodiagnosis 2018
• Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring 17p deletion. 2018
• Primary effusion lymphoma-like lymphoma with a T cell phenotype 2018
• Three coexisting lymphomas in a single patient: Composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma. 2018
• Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis? 2018
• Sj?gren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis.  2018
• Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma. 2018
• Characteristics of circulating tumor DNA in lung cancer patients.  2018
• ABL Tyrosine Kinase Inhibitors and Minimal Residual Disease Negativity during Treatment and Stop  2018
• Evaluation of low level detection of major BCR-ABL1 mRNA in chronic myeloid leukemia (DOMEST additional study) 2018
• irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors 2018
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy 2018
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier? 2018
• Investigation of origin of circulating free DNA: Is EV the carrier?  2018
• An Effect of Clarthromycin Treatment in HDM-Induced Allergic Airway Inflammation in Mice 2018
• Characteristics of circulating free DNA in lung cancer patients.  2018
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary 2018
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier? 2018
• Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group. 2018
• Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report. 2017
• Elderly patients with chronic myeloid leukemia benefit from a dasatinib dose as low as 20 mg. 2017
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer. 2017
• Peculiar cold-induced leukoagglutination in Mycoplasma pneumoniae pneumonia. 2017
• Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer. 2017
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. 2017
• Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance. 2017
• Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia  2017
• Thin-section CT findings of multicentric Castleman disease changing over 10 years. 2017
• Pre-existing chronic interstitial pneumonia is poor prognostic factor of Goodpasture's syndrome: a case and review of the literature 2017
• Saturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat Diet. 2017
• Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement 2017
• Successful Autologous Hematopoietic Stem Cell Transplantation Followed by Bortezomib Maintenance in a Patient with Relapsed CD138-low Multiple Solitary Plasmacytomas Harboring a 17p Deletion. 2017
• Primary effusion lymphoma-like lymphoma with a T cell phenotype 2017
• Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma 2017
• Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma 2017
• Characteristics of cell free DNA in lung cancer patients. 2017
• Characteristics of cell free DNA in lung cancer patients. 2017
• Allelic polymorphisms of KIR and HLA predict favorable responses to TKIs in CML patients. 19th Annual John Goldman Conference on Chronic Myeloid Leukemia:  2017
• Downregulation of BMI-1 by the small molecule PTC596 induces mitochondrial apoptosis in mantle cell lymphoma 2017
• Correlation and problems of re-biopsy and liquid biopsy for detecting T790M mutation. 2017
• Clarification of mechanisms of acquired resistance for afatinib using plasma samples. 2017
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate. 2017
• Automatic Digital Quantification of Bone Marrow Myeloma Volume in Appendicular Skeletons ? Clinical Implications and Prognostic Significance 2017
• Recruited lung macrophages contribute to progression of airway inflammation in obesity asthma mice model.  2017
• IMPACT OF KIR3DL1*00501 IN TYROSINE KINASE INHIBITOR-TREATED CML 2017
• 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10) 2017
• Paraneoplastic sarcoidosis in multiple myeloma 2017
• Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease 2017
• The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells 2017
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients 2017
• Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients 2017
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation 2016
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer 2016
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation 2016
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer 2016
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model 2016
• A retrospective analysis of the efficacy and safety of ALK inhibitors in ALK-positive lung cancer patients 2016
• Molecular target therapy and new technologies 2016
• Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma 2016
• Acute Megakaryoblastic Leukemia with Myelodysplasia-related Changes Associated with ATM Gene Deletion. 2016
• Subdural hematoma associated with dasatinib and intrathecal methotrexate treatment in Philadelphia chromosome-positive acute lymphoblastic leukemia. 2016
• Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report. 2016
• Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature. 2016
• Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia 2016
• Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus. 2016
• Domino-style cerebral bleeding in immune thrombocytopenic purpura. 2016
• Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature. 2016
• Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemia 2016
• Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia. 2016
• Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model. 2016
• Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study. 2016
• Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations. 2016
• Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia. 2016
• Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. 2016
• The combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells. 2016
• Rapid sensitive analysis of IDH-1 mutation in low-grade gliomas by automated genetic typing involving a quenching probe. 2016
• SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer. 2016
• The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma. 2016
• The MEK Inhibitor Trametinib Separates Murine Graft-versus-Host Disease from Graft-versus-Tumor Effects. 2016
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin. 2016
• For Hanshin-Saga Collaborative Cancer Study Group. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study. 2016
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma. 2015
• Hairy cell leukemia with systemic lymphadenopathy: Detection of BRAF mutation in a lymph node specimen. 2015
• A case of relapsing polychondritis successfully treated with combination of a glucocorticoid and cyclosporine. 2015
• Rituximab-containing chemotherapy (R-CHOP)-induced Kaposi’s sarcoma in an HIV-negative patient with diffuse large B cell lymphoma. 2015
• Spontaneous regression of methotrexate related lymphoproliferative disorder with T cell large granular lymphocytosis. 2015
• Monocytes IL-33 contributes to HDM-induced allergic airway inflammation 2015
• The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects. 2015
• The MEK inhibitior Trametinib selectively suppresses Graft-versus-Host Disease (GVHD), while sparing Graft-versus-Tumor (GVT) effects. 2015
• SPARC, a possible predictive marker to albumin-bound paclitaxel (nab-paclitaxel) in non-small cell lung cancer 2015
• Potential predictive markers for re-challenge with first generation and second generation EGFR-TKI 2015
• Clinical features and treatment outcomes of acute erythroid leukemia in the last decade 2015
• 2-Hydroxypropyl-β-cyclodextrin Acts as a Novel Anticancer Agent. 2015
• Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer. 2015
• Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells. 2015
• Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia. 2015
• Discontinuation of dasatinib in chronic myeloid leukaemia patients who have maintained deep molecular response for more than 1 year: the prospective, multicentre Dasatinib Discontinuation (DADI) Trial. 2015
• Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity 2015
• Preclinical activity of the novel BMI-1 inhibitor PTC-209 in acute myeloid leukemia: implications for leukemia therapy. 2015
• Volume-based response evaluations with consensual lesion selection using cloud solutions (SaaS) in clinical trials: a pilot study 2015
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 2015
• Comparative study of the anti-leukemic effects of imatinib mesylate, GlivecTM tablet and its generic formulation, OHK9511 2015
• Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia. 2015
• Coexistence of ALK- anaplastic large cell lymphoma and CD4+ T cell large granular lymphocytic leukemia. 2015
• Ever-advancing chronic myeloid leukemia treatment 2014
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma. 2014
• A novel frameshift mutation in exon 4 causes deficiency of high molecular weight kininogen 2014
• Small lymphocytic lymphoma presenting as bulky renal incidentaloma. 2014
• 2 Adrenergic Agonist Attenuates HDM-induced Allergic Airway Inflammation through Dendritic Cells. 2014
• Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia. 2014
• Bilateral renal infiltration as the initial presentation of multiple myeloma. 2014
• Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: A potential treatment for BCR-ABL positive leukemia 2014
• Ohyashiki K. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL–positive leukemia cells involves the ABL kinase domain mutation. 2014
• Mogamulizumab treatment in a hemodialysis patient with adult T-cell leukemia/lymphoma. 2014
• Induction of p53 transcription and apoptosis by Exportin-1 (XPO1) inhibition in mantle cell lymphoma. 2014
• ABL tyrosine kinase inhibitor–induced pulmonary alveolar proteinosis in chronic myeloid leukemia. 2014
• Correlation between plasma DNA and tumor status in an animal model.  2014
• Volume-based response evaluations with consensual lesion selection using cloud solutions in clinical trials: a pilot study 2014
• Efficacy and toxicity of mogamulizumab for relapsed/refractory adult T-cell leukemia-lymphoma: a retrospective analysis in Saga prefecture, Japan 2014
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent.  2014
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 2014
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer 2014
• Non-invasive monitoring system for acquired resistance to EGFR-tyrosine kinase inhibitors using circulating plasma DNA 2014
• Monitoring of EGFR T790M with plasma in lung cancer patients 2014
• Ⅲ (EFM) patient with rare genotype expressing anti-E antibody after transfusion of platelet concentrates 2014
• Anti-proliferative effect of 2-hydroxypropyl-β-cyclodextrin against chronic myeloid leukemia 2014
• Low-dose dasatinib treatment for elderly CML patients 2014
• Two cases of meningeal infiltration with adult T cell leukemia/lymphoma after mogamulizumab treatment 2014
• Three cases of hemodialysis patients with advanced gastric cancer treated with Paclitaxel and nab paclitaxel 2014
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia 2014
• Two cases of immune thrombocytopenic purpura with multiple cerebral microbleeds 2014
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors. 2014
• SPARC, as a possible predictive marker for albumin-bound paclitaxel in non-small cell lung cancer 2014
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent. 2014
• Small lymphocytic lymphoma presenting as bulky renal incidentaloma 2014
• Correlation between plasma DNA and tumor status in an animal model on metastasis of lung cancer 2014
• Brainstem Encephalitis with anti-ganglioside antibody associated with mogamulizumab treatment 2014
• Therapeutic management in cardiac lymphoma. 2014
• Neuroprotective efficacy of a new brain-penetrating c-Abl inhibitor in a murine Parkinson's disease model. 2013
• Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells. 2013
• Development of lymphoproliferative diseases by hypoxia inducible factor-1 is associated with prolonged lymphocyte survival. 2013
• Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival. 2013
• Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy. 2013
• Targeting the hedgehog signaling pathway in therapy-resistant BCR-ABL1 positive leukemia with ponatinib. 2013
• Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study. 2013
• Ever-advancing chronic myeloid leukemia treatment 2013
• Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. 2013
• Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients. 2013
• β-2 microglobulin is unsuitable as an internal reference for the analysis of gene expression in human colorectal cancer 2013
• An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C. 2013
• Induction of p53 Transcription and Apotosis by XPO1 Inhibition in Mantle Cell Lymphoma. 2013
• Establishment of animal model for metastasis of human lung cancers using NOJ/SCID mice. 2013
• Establishment of a rapid and automated detection system for BRAF mutations in malignant melanoma. 2013
• Non-invasive monitoring system using circulating plasma DNA 2013
• A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids 2013
• Deferasirox in iron-overloaded patients with hematologic diseases at Saga University Hospital 2013
• Therapeutic management in cardiac lymphoma 2013

Books

• Recurrent DLBCL Developing Small Bowel Lesion of Stenotic Type, Report of a Case;　2023/07
  ANNOUNCEMENT INFO.;　Stomach and Intestine, 58, 7, 929-935
  AUTHOR;　○Motohiro Esaki, Takashi Akutagawa, Ryo Shimoda, Takahiro Yukimoto, Takuya Shimamura, Hidekazu Itamura, Yukie Yoda, Keita Kai, Keisuke Kawasaki, Shinya Kimura, Hirokazu Noshiro
  
• 慢性骨髄性白血病;　2023/01
  ANNOUNCEMENT INFO.;　, 671-674
  AUTHOR;　
  

Original Articles

• Development of a specific and sensitive sandwich enzyme-linked immunosorbent assay for the quantification of dasatinib;　2023/08
  ANNOUNCEMENT INFO.;　Anal Biochem, 678, 115272
  AUTHOR;　*Kataoka H, Saita T, Yamamoto Y, Sogawa R, Kimura S, Kimura S, Shimanoe C
  
• Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper Cells: A Case Report;　2023/05
  ANNOUNCEMENT INFO.;　Intern Med, 62, 9, 1335-1340
  AUTHOR;　Ishii K, Kamachi K, Okamoto S, Katsuya H, Fujita M, Nagaie T, Nishioka A, Yoshimura M, Ureshino H, Kubota Y, Ando T, Watanabe T, Takeuchi M, Kai K, Ohshima K, Kimura S
  
• Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study ;　2023/05
  ANNOUNCEMENT INFO.;　Int J Hematol, 117, 5, 694-705
  AUTHOR;　*Yoshida C, Yamaguchi H, Doki N, Murai K, Iino M, Hatta Y, Onizuka M, Yokose N, Fujimaki K, Hagihara M, Oshikawa G, Murayama K, Kumagai T, Kimura S, Najima Y, Iriyama N, Tsutsumi I, Oba K, Kojima H, Sakamaki H, Inokuchi K; Kanto CML Study Group
  
• Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL;　2023/04
  ANNOUNCEMENT INFO.;　Blood Adv, 7, 8, 1545-1559
  AUTHOR;　Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Yamashita S, Hattori N, Nakamura H, Kawaguchi A, Ushijima T, Sueoka E, Kimura S
  
• Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia ;　2023/04
  ANNOUNCEMENT INFO.;　Cancer Sci, 114, 4, 1297-1308
  AUTHOR;　*Wakita S, Marumo A, Morita K, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Nakayama K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Tashiro H, Sakaguchi M, Yui S, Arai K, Kitano T, Miyata M, Arai H, Kanda M, Itabashi K, Fukuda T, Kanda Y, Yamaguchi H
  
• Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia ;　2023/04
  ANNOUNCEMENT INFO.;　Bone Marrow Transplant, 58, 4, 465-468
  AUTHOR;　Katsuya H, Yamaguchi K, Dung TC, Sano H, Itamura H, Okamoto S, Yoshimura M, Ureshino H, Ando T, Zaimoku Y, Nakao S, Kimura S
  
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer;　2023/03
  ANNOUNCEMENT INFO.;　Oncol Lett, 25, 5, 180
  AUTHOR;　Harada Y, Sato A, Nishioka A, Ogusu S, Matsumoto M, Sueoka E, Kawaguchi A, Kimura S, Sueoka-Aragane N
  
• Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia ;　2023/02
  ANNOUNCEMENT INFO.;　Cancer Res Commun, 3, 2, 297-308
  AUTHOR;　Kamachi K, Ureshino H, Watanabe T, Yoshida-Sakai N, Fukuda-Kurahashi Y, Kawasoe K, Hoshiko T, Yamamoto Y, Kurahashi Y, Kimura S
  
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer ;　2023/01
  ANNOUNCEMENT INFO.;　BMC Cancer, 23, 1, 77
  AUTHOR;　Harada Y, Sato A, Nakamura H, Kai K, Kitamura S, Nakamura T, Kurihara Y, Ikeda S, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Effect of Azithromycin on Exacerbations in Asthma Patients with Obesity: Protocol for a Multi-Center, Prospective, Single-Arm Intervention Study ;　2023/01
  ANNOUNCEMENT INFO.;　Int J Environ Res Public Health, 20, 3, 1861
  AUTHOR;　○Tashiro H, Takahashi K, Uchida M, Kurihara Y, Sadamatsu H, Takamori A, Kimura S, Sueoka-Aragane N
  
• Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice;　2023
  ANNOUNCEMENT INFO.;　, S1323-8930, 23, 00122-3
  AUTHOR;　Kurihara Y, Tashiro H, Konomi Y, Sadamatsu H, Ihara S, Takamori A, Kimura S, Sueoka-Aragane N, Takahashi K
  
• Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study;　2023
  ANNOUNCEMENT INFO.;　, 10, 1, e001607
  AUTHOR;　Takahashi K, Kawayama T, Takamori A, Tashiro H, Kinoshita T, Takagi K, Yamasaki K, Machida K, Kawaguchi A, Yatera K, Inoue H; TRACK (Triple therapy for Japanese with mild to moderate COPD in Kyushu) study investigator group.
  
• Simultaneous detection of JAK2, CALR, and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe-Tm method in i-densy IS-5320;　2022/12
  ANNOUNCEMENT INFO.;　Int J Lab Hematol, 44, 6, 1102-1110
  AUTHOR;　*Kunihito Arai, Masahiro Sakaguchi, Shunsuke Yui, Tomoaki Kitano, Miho Miyata, Mayumi Yogosawa, Kazutaka Nakayama, Kenji Tajika, Kensuke Usuki, Junya Kuroda, Nobuhiko Uoshima, Yutaka Kobayashi, Hitoji Uchiyama, Yasushi Kubota, Shinya Kimura, Shinichiro Mori, Mitsuharu Hirai, Satoshi Wakita, Hiroki Yamaguchi
  
• Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath;　2022/12
  ANNOUNCEMENT INFO.;　Thorac Cancer, 13, 24, 3459-3466
  AUTHOR;　○Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Ryo Tajiri, Yuki Kuwahara, Kokoro Kajiwara, Natsuko Komiya, Shinsuke Ogusu, Chiho Nakashima, Tomomi Nakamura, Shinya Kimura, Naoko Sueoka-Aragane
  
• Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia ;　2022/10
  ANNOUNCEMENT INFO.;　Indian J Hematol Blood Transfus, 38, 4, 760-761
  AUTHOR;　*Ureshino H, Kamachi K, Shindo T, Kimura S
  
• Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma;　2022/09
  ANNOUNCEMENT INFO.;　Sci Rep, 12, 1, 16457
  AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Yuki Kuwahara, Ryo Tajiri, Shinya Kimura, Naoko Sueoka-Aragane
  
• NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia ;　2022/08
  ANNOUNCEMENT INFO.;　Int J Hematol, 116, 2, 199-214
  AUTHOR;　*Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Iekuni Oh, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Yasushi Kubota, Shinya Kimura, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Kenta Date, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Kazuteru Ohashi, Yoshinobu Kanda, Hiroki Yamaguchi
  
• Association of orexin receptor antagonists with falls during hospitalization ;　2022/06
  ANNOUNCEMENT INFO.;　J Clin Pharm Ther, 47, 6, 809-813
  AUTHOR;　○Rintaro Sogawa, Akiko Emoto, Akira Monji, Yuki Miyamoto, Misako Yukawa, Toru Murakawa-Hirachi, Yasuhiro Tagomori, Mikiko Kawasaki, Shinya Kimura, Chisato Shimanoe
  
• Correction: HLA Polymorphisms Are Associated With Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia ;　2022/05
  ANNOUNCEMENT INFO.;　Mol Cancer Ther, 21, 5, 855
  AUTHOR;　Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura
  
• Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism ;　2022/04
  ANNOUNCEMENT INFO.;　Int J Cancer, 150, 7, 1184-1197
  AUTHOR;　Nao Yoshida-Sakai, Tatsuro Watanabe, Yuta Yamamoto, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Shinya Kimura
  
• Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia ;　2022/02
  ANNOUNCEMENT INFO.;　Cancer Lett, 526, 273-283
  AUTHOR;　Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, Nao Yoshida, Yuta Yamamoto, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Yoshihiro Hayashi, Hideyo Hirai, Satoshi Yamashita, Toshikazu Ushijima, Seiji Okada, Shinya Kimura
  
• RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia ;　2022/02
  ANNOUNCEMENT INFO.;　Cancer Sci, 113, 2, 529-539
  AUTHOR;　*Tatsuya Masuda, Shintaro Maeda, Sae Shimada, Naoya Sakuramoto, Ken Morita, Asami Koyama, Kensho Suzuki, Yoshihide Mitsuda, Hidemasa Matsuo, Hirohito Kubota, Itaru Kato, Kuniaki Tanaka, Junko Takita, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Souichi Adachi, Hideyo Hirai, Shuichi Mizuta, Kazuhito Naka, Yoichi Imai, Shinya Kimura, Hiroshi Sugiyama, Yasuhiko Kamikubo
  
• Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series;　2022/02
  ANNOUNCEMENT INFO.;　J Asthma Allergy, 15, 169-177
  AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Yuki Kuwahara, Shinya Kimura, Naoko Sueoka-Aragane
  
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test ;　2022/02
  ANNOUNCEMENT INFO.;　Cell Oncol (Dordr), 45, 1, 121-134
  AUTHOR;　Yohei Harada, Akemi Sato, Mitsugu Araki, Shigeyuki Matsumoto, Yuta Isaka, Yukari Sagae, Tomonori Abe, Yasuko Aoyagi, Eisaburo Sueoka, Yasushi Okuno, Shinya Kimura, Naoko Sueoka-Aragane
  
• Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals ;　2022/01
  ANNOUNCEMENT INFO.;　J Infect Dis, 225, 2, 359
  AUTHOR;　Hiroo Katsuya, Lucy B M Cook, Aileen G Rowan, Anat Melamed, Jocelyn Turpin, Jumpei Ito, Saiful Islam, Paola Miyazato, Benjy Jek Yang Tan, Misaki Matsuo, Toshikazu Miyakawa, Hirotomo Nakata, Shuzo Matsushita, Graham P Taylor, Charles R M Bangham, Shinya Kimura, Yorifumi Satou
  
• Expression level of BTN3A1 on the surface of CD14 + monocytes is a potential predictor of γδ T cell expansion efficiency ;　2022/01
  ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun, 588, 47-54
  AUTHOR;　*Tomogane M, Omura M, Sano Y, Shimizu D, Toda Y, Hosogi S, Kimura S, Ashihara E
  
• Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia ;　2022/01
  ANNOUNCEMENT INFO.;　Blood Adv, 6, 1, 238-247
  AUTHOR;　*Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H
  
• Clonality of HIV-1 and HTLV-1 infected cells in naturally coinfected individuals ;　2022/01
  ANNOUNCEMENT INFO.;　J Infect Dis, 225, 2, 317-326
  AUTHOR;　Hiroo Katsuya, Lucy B M Cook, Aileen G Rowan, Anat Melamed, Jocelyn Turpin, Jumpei Ito, Saiful Islam, Paola Miyazato, Benjy Jek Yang Tan, Misaki Matsuo, Toshikazu Miyakawa, Hirotomo Nakata, Shuzo Matsushita, Graham P Taylor, Charles R M Bangham, Shinya Kimura, Yorifumi Satou
  
• Clinical Studies HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide for adult T-cell leukemia;　2022
  ANNOUNCEMENT INFO.;　Rinsho Ketsueki, 63, 5, 333-340
  AUTHOR;　Keitaro ISHII, Sho OKAMOTO, Mai FUJITA, Ayano SUGIHARA, Toshiaki NAGAIE, Atsujiro NISHIOKA, Kazuharu KAMACHI, Hidekazu ITAMURA, Hiroo KATSUYA, Mariko YOSHIMURA, Hiroshi URESHINO, Toshihiko ANDO, Yasushi KUBOTA, Shinya KIMURA
  
• Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial ;　2021/12
  ANNOUNCEMENT INFO.;　Lancet Haematol, 8, 12, e902-e911
  AUTHOR;　*Kazunori Murai, Hiroshi Ureshino, Takashi Kumagai, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Nobuhiko Uoshima, Toru Kiguchi, Masayuki Mita, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda, Kensuke Nakao, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yousuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
  
• Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease;　2021/12
  ANNOUNCEMENT INFO.;　Int J Chron Obstruct Pulmon Dis, 16, 3297-3307
  AUTHOR;　○Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Masaru Uchida, Go Kato, Yuki Kurihara, Hironori Sadamatsu, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama, Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
  
• Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors ;　2021/11
  ANNOUNCEMENT INFO.;　Cancers (Basel), 13, 21, 5543
  AUTHOR;　*Hyeok-Jae Jang, Young-Min Woo, Kazuhito Naka, Jong-Ho Park, Ho-Jae Han, Hee-Jin Kim, Sun-Hee Kim, Jae-Sook Ahn, Taehyung Kim, Shinya Kimura, Sarah Zarabi, Jeffrey H Lipton, Mark D Minden, Chul-Won Jung, Hyeoung-Joon Kim, Jong-Won Kim, Dennis Dong Hwan Kim
  
• Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells;　2021/10
  ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun, 573, 132-139
  AUTHOR;　*Mako Tomogane, Yusuke Sano, Daiki Shimizu, Teruki Shimizu, Masatsugu Miyashita, Yuki Toda, Shigekuni Hosogi, Yoshimasa Tanaka, Shinya Kimura, Eishi Ashihara
  
• Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience ;　2021/10
  ANNOUNCEMENT INFO.;　Hematol Oncol, 39, 4, 549-557
  AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, Sho Okamoto, Hiroo Katsuya, Mariko Yoshimura, Yasushi Kubota, Toshihiko Ando, Shinya Kimura
  
• Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death ;　2021/10
  ANNOUNCEMENT INFO.;　Cancers (Basel), 13, 21, 5413
  AUTHOR;　Toshimi Hoshiko, Yasushi Kubota, Risako Onodera, Taishi Higashi, Masako Yokoo, Keiichi Motoyama, Shinya Kimura
  
• Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD ;　2021/09
  ANNOUNCEMENT INFO.;　Cell Immunol, 367, 104410
  AUTHOR;　Hidekazu Itamura, Takero Shindo, Hiroyuki Muranushi, Kazutaka Kitaura, Seiji Okada, Tadasu Shin-I , Ryuji Suzuki, Akifumi Takaori-Kondo, Shinya Kimura
  
• Non-valvular Infective Endocarditis Caused by Sarocladium kiliense in an Immunocompromised Patient with Aplastic Anemia: A Case Report ;　2021/09
  ANNOUNCEMENT INFO.;　Intern Med
  AUTHOR;　Hiroaki Kitamura, Yasushi Kubota, Rika Tomimasu, Michiaki Akashi, Tadashi Mori, Yutaro Mine, Jun Ando, Somay Yamagata Murayama, Shinya Kimura, Masaharu Miyahara
  
• Severity of constipation related to palonosetron during first-line chemotherapy: a retrospective observational study ;　2021/08
  ANNOUNCEMENT INFO.;　Support Care Cancer, 29, 8, 4723-4732
  AUTHOR;　○Sakiko Kimura, Kazuhisa Hosoya, Kenji Ogata, Tatsuya Furuno, Rintaro Sogawa, Koji Takeuchi, Masanobu Tasaki, Atsushi Kawaguchi, Atsujiro Nishioka, Naoko Sueoka-Aragane, Hirokazu Noshiro, Yuichiro Kuratomi, Masatoshi Yokoyama, Mitsuru Noguchi, Keizo Anzai, Yoshio Yamashita, Shinya Kimura, Hiroyuki Irie
  
• Silylation of deoxynucleotide analog yields an orally available drug with anti-leukemia effects ;　2021/08
  ANNOUNCEMENT INFO.;　Mol Cancer Ther, 20, 8, 1412-1421
  AUTHOR;　Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe, Satoshi Yamashita, Kazuharu Kamachi, Yuta Yamamoto, Yuki Fukuda-Kurahashi, Nao Yoshida-Sakai, Naoko Hattori, Yoshihiro Hayashi, Atsushi Kawaguchi, Kaoru Tohyama, Seiji Okada, Hironori Harada, Toshikazu Ushijima, Shinya Kimura
  
• Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease ;　2021/08
  ANNOUNCEMENT INFO.;　Sci Rep, 11, 1, 15862
  AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Masahide Tanaka, Hironori Sadamatsu, Yuki Kurihara, Ryo Tajiri, Ayako Takamori, Hiroyuki Naotsuka, Hiroki Imaizumi, Shinya Kimura, Naoko Sueoka-Aragane
  
• Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab ;　2021/07
  ANNOUNCEMENT INFO.;　Indian J Hematol Blood Transfus, 37, 3, 509-510
  AUTHOR;　*Hiroaki Kitamura, Yasushi Kubota, Rika Tomimasu, Haruki Hirakawa, Hiroshi Inoue, Hitomi Umeguchi, Moeko Yoshida, Hideki Akahoshi, Shiho Tsuruda, Rie Ide, Shinya Kimura, Masaharu Miyahara
  
• Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia ;　2021/06
  ANNOUNCEMENT INFO.;　Immunol Med, 44, 2, 61-68
  AUTHOR;　*Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura
  
• Prolonged gastric mucosal haemorrhage following 5-azacitidine administration in a patient with acute myeloid leukaemia.;　2021/05
  ANNOUNCEMENT INFO.;　*/eJHaem/*,2021 May 1;2(3):653-654.
  AUTHOR;　Kitamura H, Miyahara K, Kubota Y, Tomimasu R, _Kimura S_, Miyahara M.
  
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies ;　2021/05
  ANNOUNCEMENT INFO.;　BMC Cancer, 21, 1, 584
  AUTHOR;　○Akiko Matsumoto, Chiho Nakashima, Shinya Kimura, Eizaburo Sueoka, Naoko Aragane
  
• Evolution of CML treatment ;　2021/05
  ANNOUNCEMENT INFO.;　Int J Hematol, 113, 5, 622-623
  AUTHOR;　Shinya Kimura
  
• A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease ;　2021/04
  ANNOUNCEMENT INFO.;　J Clin Med, 10, 8, 1576
  AUTHOR;　○Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Koji Kusaba, Tetsuro Haraguchi, Yuki Kurihara, Natsuko Komiya, Chiho Nakashima, Tomomi Nakamura, Shinya Kimura, Naoko Sueoka-Aragane
  
• HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia;　2021/01
  ANNOUNCEMENT INFO.;　Mol Cancer Ther, 20, 1, 142-149
  AUTHOR;　Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura
  
• Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma;　2021/01
  ANNOUNCEMENT INFO.;　Respir Investig, 59, 1, 126-134
  AUTHOR;　○Koichiro Takahashi, Hironori Sadamatsu, Kumiko Suzuki, Hiroki Tashiro, Shinya Kimura, Yuichiro Kuratomi, Naoko Sueoka-Aragane
  
• Technical Lecture Development and clinical use of an application for management of drug holidays in perioperative periods;　2021
  ANNOUNCEMENT INFO.;　Japanese Journal of Thrombosis and Hemostasis, 32, 3, 339 - 348
  AUTHOR;　○Sakiko KIMURA, Eisaburo SUEOKA, Shinya KIMURA
  
• Development of a Competitive Enzyme-Linked Immunosorbent Assay for the Determination of Sunitinib Unaffected by Light-Induced Isomerization ;　2021
  ANNOUNCEMENT INFO.;　Biol Pharm Bull, 44, 10, 1565-1570
  AUTHOR;　*Hiroto Kataoka, Tetsuya Saita, Rintaro Sogawa, Yuta Yamamoto, Shunsuke Matsuo, Sakiko Kimura, Shinya Kimura, Masashi Shin
  
• Construction of Two Box-Like Head-and-Face Shields by Japanese Origami Folding for Use During the COVID-19 Pandemic.;　2020/12
  ANNOUNCEMENT INFO.;　*/Int J Genl Med/* 2020 Dec 30:13:1669-1673.
  AUTHOR;　Tago M, Anzai K, Sakamoto Y, Hamada Y, Ishikawa S, _Kimura S_, Yamashita S.
  
• Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease;　2020/12
  ANNOUNCEMENT INFO.;　BMC Pulm Med , 20, 1, 318
  AUTHOR;　Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• Biomarkers for Overweight in Adult-Onset Asthma;　2020/10
  ANNOUNCEMENT INFO.;　J Asthma Allergy, 13, 409-414
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease;　2020/09
  ANNOUNCEMENT INFO.;　Int J Chron Obstruct Pulmon Dis, 15, 2115-2126
  AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Takashi Kinoshita, Makoto Yoshida, Ryo Tajiri, Keisuke Kojima, Hiroshi Inoue, Hiromi Kobayashi, Hironori Sadamatsu, Hiroki Tashiro, Masahide Tanaka, Shinichiro Hayashi, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama, Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
  
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis using the new oral demethylating agent OR-2100;　2020/08
  ANNOUNCEMENT INFO.;　Blood, 136, 7, 871-884
  AUTHOR;　○Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka
  
• Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells;　2020/08
  ANNOUNCEMENT INFO.;　Invest New Drugs, 38, 4, 1012-1019
  AUTHOR;　Toshimi Hoshiko, Yasushi Kubota, Takuya Akisawa, Tatsuro Watanabe, Kazuaki Tanigawara, Junichi Yano, Shinya Kimura
  
• Origin of circulating free DNA in patients with lung cancer;　2020/07
  ANNOUNCEMENT INFO.;　PLoS One, 15, 7, e0235611
  AUTHOR;　○Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Atsushi Kawaguchi, Naoko Sueoka-Aragane
  
• J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors;　2020/07
  ANNOUNCEMENT INFO.;　Int J Hematol
  AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Shinya Kimura
  
• Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors;　2020/07
  ANNOUNCEMENT INFO.;　Int J Hematol, 112, 1, 41-45
  AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Atsushi Kawaguchi, Motoaki Miyazono, Yuji Ikeda, Shinya Kimura
  
• Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease;　2020/07
  ANNOUNCEMENT INFO.;　Int J Hematol, 112, 1, 115-117
  AUTHOR;　*Jinichi Mori, Kumi Oshima, Tetsuya Tanimoto, Hikari Ishizuka, Shinya Kimura, Masatomo Miura, Naoto Takahashi
  
• Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation;　2020/06
  ANNOUNCEMENT INFO.;　Intern Med, 59, 12, 1549-1553
  AUTHOR;　Mai Fujita, Kazuharu Kamachi, Masako Yokoo, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Atsujiro Nishioka, Mariko Yoshimura, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura
  
• Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case Report;　2020/06
  ANNOUNCEMENT INFO.;　Tohoku J Exp Med, 251, 2, 81-85
  AUTHOR;　Kazuharu Kamachi, Toshihiko Ando, Nanae Tsuruoka, Mariko Hashiguchi, Keisuke Kidoguchi, Kana Kusaba, Haruna Sano, Haruhiko Sano, Kyosuke Yamaguchi, Atsujiro Nishioka, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura
  
• Does patient sex play a role in treatment-free remission in chronic myeloid leukemia?;　2020/06
  ANNOUNCEMENT INFO.;　Int J Hematol, 111, 6, 903
  AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
  
• Venue of catheter insertion does not significantly impact the event of central line-associated bloodstream infection in patients with haematological diseases;　2020/06
  ANNOUNCEMENT INFO.;　Infection Prevention in Practice, 2, 2, 1-8
  AUTHOR;　Kitamura H, Kubota Y, Komukai S, Yoshida H, Kaneko Y, Mihara Y, Nagasawa Z, Kawaguchi A, Aoki Y, Kimura S
  
• Development of an application for management of drug holidays in perioperative periods;　2020/05
  ANNOUNCEMENT INFO.;　Medicine (Baltimore), 99, 19, e20142
  AUTHOR;　○Sakiko Kimura, Akiko Emoto, Mariko Yoshimura, Kota Arimizu, Tomoko Kamura, Rintaro Sogawa, Kikumi Mizuta, Yasuhiro Tagomori, Masahiro Natsuaki, Masataka Kajiwara, Nanae Tsuruoka, Yusuke Yakushiji, Yoshinori Tanigawa, Chihiro Takamatsu, Atsushi Danjo, Keiji Kamohara, Naomi Hirakawa, Yoshiro Sakaguchi, Mitsuru Noguchi, Hirokazu Noshiro, Atsushi Kawaguchi, Eisaburo Sueoka, Yutaka Narisawa, Shinya Kimura
  
• Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis;　2020/04
  ANNOUNCEMENT INFO.;　BMC Pulm Med, 20, 1, 116
  AUTHOR;　○Hiroki Tashiro, Tetsuro Haraguchi, Koichiro Takahashi, Hironori Sadamatsu, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• Budget impact analysis of treatment-free remission in nilotinib-treated Japanese chronic myeloid leukemia patients;　2020/04
  ANNOUNCEMENT INFO.;　Cancer Sci
  AUTHOR;　*Kiyotaka Yamazaki, Naohito Inagaki, Daniel Moldaver, Ricardo Viana, Shinya Kimura
  
• Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury;　2020/04
  ANNOUNCEMENT INFO.;　Ann Hematol, 99, 4, 885-886
  AUTHOR;　Keisuke Kidoguchi, Masako Yokoo, Akihisa Umino, Shigehisa Aoki, Shinya Kimura
  
• Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial;　2020/03
  ANNOUNCEMENT INFO.;　Lancet Haematol, 7, 3, e218-e225
  AUTHOR;　Shinya Kimura, Jun Imagawa, Kazunori Murai, Masayuki Hino, Toshio Kitawaki, Masaya Okada, Hideo Tanaka, Motohiro Shindo, Takashi Kumagai, Takayuki Ikezoe, Nobuhiko Uoshima, Tsutomu Sato, Reiko Watanabe, Shugo Kowata, Masaya Hayakawa, Takaaki Hosoki, Kazuhiko Ikeda, Tsutomu Kobayashi, Yasutaka Kakinoki, Tetsuo Nishimoto, Naoki Takezako, Hirohiko Shibayama, Akifumi Takaori-Kondo, Hirohisa Nakamae, Atsushi Kawaguchi, Hiroshi Ureshino, Junichi Sakamoto, Yoji Ishida, DADI Trial Group
  
• Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation;　2020/02
  ANNOUNCEMENT INFO.;　Blood Adv, 4, 4, 667-671
  AUTHOR;　Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura
  
• Clinical impact of the CONUT score in patients with multiple myeloma;　2020/01
  ANNOUNCEMENT INFO.;　Ann Hematol, 99, 1, 113-119
  AUTHOR;　Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Haruhiko Sano, Atsujiro Nishioka, Kyosuke Yamaguchi, Kazuharu Kamachi, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Atsushi Kawaguchi, Eisaburo Sueoka, Shinya Kimura
  
• The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model;　2020/01
  ANNOUNCEMENT INFO.;　Inflamm Res. , 69, 1, 139-151
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Noguchi Y, Kurata K, Ōmura S, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma;　2020
  ANNOUNCEMENT INFO.;　Int Arch Allergy Immunol, 181, 9, 665-674
  AUTHOR;　○Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Yuki Kurihara, Go Kato, Masaru Uchida, Yoshihiko Noguchi, Keigo Kurata, Satoshi Ōmura, Toshiaki Sunazuka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea;　2020
  ANNOUNCEMENT INFO.;　In Vivo, 34, 3, 1415-1419
  AUTHOR;　Rintaro Sogawa, Chiho Nakashima, Tomomi Nakamura, Koji Takeuchi, Sakiko Kimura, Kazutoshi Komiya, Yutaka Narisawa, Shinya Kimura, Naoko Sueoka-Aragane
  
• The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma.;　2020/00
  ANNOUNCEMENT INFO.;　*//**/Int Arch Allergy Immunol/*2020;181(9):665-674.
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kurihara Y, Kato G, Uchida M, Noguchi Y, Kurata K, Omura S, Sunazuka T, Kimura S. Sueoka-Aragane N.
  
• POSITIVE RATE OF BLOOD PRODUCTS IN THE IRREGULAR ANTIBODY SCREENING TEST AND THE SIGNIFICANCE OF MINOR CROSSMATCHING IN THE CROSSMATCH TEST;　2019/12
  ANNOUNCEMENT INFO.;　, 65, 6, 865-869
  AUTHOR;　Marie Yamada, Naotomo Yamada, Mami Nakao, Yasushi Kubota, Shinya Kimura, Eisaburo Sueoka
  
• Immunohistochemical localization of afatinib in male rat intestines and skin after its oral administration;　2019/11
  ANNOUNCEMENT INFO.;　Acta Histochem, 121, 8, 151439
  AUTHOR;　*Yutaro Yamamoto, Tetsuya Saita, Yuta Yamamoto, Rintaro Sogawa, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
  
• Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.;　2019/11
  ANNOUNCEMENT INFO.;　Int J Hematol. , 110, 5, 566-574
  AUTHOR;　＊Sakaguchi M, Yamaguchi H, Kuboyama M, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Date K, Nakajima N, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.
  
• Japan's high-cost medical expense benefit system could be an obstacle to promoting generic imatinib;　2019/10
  ANNOUNCEMENT INFO.;　Lancet Haematol, 6, 10, e498
  AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
  
• Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells.;　2019/10
  ANNOUNCEMENT INFO.;　Invest New Drugs, 38, 4, 1012-1019
  AUTHOR;　Hoshiko T, Kubota Y, Akisawa T, Watanabe T, Tanigawara K, Yano J, Kimura S.
  
• Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.;　2019/09
  ANNOUNCEMENT INFO.;　Thorac Cancer. , 10, 9, 1798-1804
  AUTHOR;　Komiya K, Nakamura T, Abe T, Ogusu S, Nakashima C, Takahashi K, Kimura S, Sueoka-Aragane N
  
• Assessment of tumor volume and density as a measure of the response of advanced hepatocellular carcinoma to sorafenib: Application of automated measurements on computed tomography scans;　2019/08
  ANNOUNCEMENT INFO.;　JGH Open, 4, 2, 145-152
  AUTHOR;　*Junta Yamamichi, Yasunori Kawaguchi, Taiga Otsuka, Shunya Nakashita, Hideaki Mizobe , Yuichiro Eguchi, Shinya Kimura
  
• Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy;　2019/06
  ANNOUNCEMENT INFO.;　Ann Hematol, 98, 6, 1501-1503
  AUTHOR;　Masako Yokoo, Kensuke Kojima, Haruna Sano, Keita Kai, Fumiko Arakawa, Koichi Ohshima, Taketo Matsunaga, Shinya Kimura
  
• HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia;　2019/06
  ANNOUNCEMENT INFO.;　Leukemia, 33, 6, 1439-1450
  AUTHOR;　*Jong-Ho Park, Young Min Woo, Emilia Moonkyung Youm, Nada Hamad, Hong-Hee Won, Kazuhito Naka, Eun-Ju Park, June-Hee Park, Hee-Jin Kim, Sun-Hee Kim, Hyeoung-Joon Kim, Jae Sook Ahn, Sang Kyun Sohn, Joon Ho Moon, Chul Won Jung, Silvia Park, Jeffrey H Lipton, Shinya Kimura, Jong-Won Kim, Dennis Dong Hwan Kim
  
• Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma;　2019/06
  ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk, 19, 6, 326-331
  AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
  
• Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis;　2019/05
  ANNOUNCEMENT INFO.;　Ann Hematol, 98, 5, 1305-1307
  AUTHOR;　Keisuke Kidoguchi, Mariko Yoshimura, Kensuke Kojima, Hiroshi Ureshino, Ryoko Egashira, Masako Yokoo, Keita Kai, Yoshiaki Egashira, Koichi Ohshima, Toshihiko Ando, Shinya Kimura
  
• Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum;　2019/04
  ANNOUNCEMENT INFO.;　Anal Biochem, 571, 14-20
  AUTHOR;　*Yuta Yamamoto, Tetsuya Saita, Rintaro Sogawa, Kenji Ogata, Yutaro Yamamoto, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
  
• Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial);　2019/04
  ANNOUNCEMENT INFO.;　Int J Clin Oncol, 24, 4, 445-453
  AUTHOR;　*Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, Hajime Kobayashi, Eisei Kondo, Noriko Doki, Takafumi Nakao, Yoshinobu Kanda, Nobuharu Kosugi, Hiroshi Kosugi, Takashi Kumagai, Hiroshi Harada, Masato Shikami, Yasuhiro Maeda, Toru Sakura, Koiti Inokuchi, Akio Saito, Yuichiro Nawa, Masahiro Ogasawara, Junji Nishida, Takeshi Kondo, Chikashi Yoshida, Hiroyuki Kuroda, Yoko Tabe, Yoshinobu Maeda, Kenji Imajo, Kensuke Kojima, Satoshi Morita, Sho Komukai, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
  
• A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib;　2019/03
  ANNOUNCEMENT INFO.;　PLoS One, 14, 3, e0207170
  AUTHOR;　Hiroaki Kitamura, Yoko Tabe, Tomohiko Ai, Koji Tsuchiya, Maiko Yuri, Shigeki Misawa, Takashi Horii, Atsushi Kawaguchi, Akimichi Ohsaka, Shinya Kimura
  
• Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?;　2019/03
  ANNOUNCEMENT INFO.;　*/Int J Hematol/*, 2019 Mar;109(3):247-248.
  AUTHOR;　Kidoguchi K, Kojima K, Seki R, Nagafuji K, Oshima K, _Kimura S_.
  
• C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells;　2019/02
  ANNOUNCEMENT INFO.;　Blood Adv, 3, 3, 476-488
  AUTHOR;　*Asumi Yokota, Hideyo Hirai, Ryuichi Sato, Hiroko Adachi, Fumiko Sato, Yoshihiro Hayashi , Atsushi Sato, Naoka Kamio, Yasuo Miura, Masakazu Nakano, Daniel G Tenen, Shinya Kimura, Kei Tashiro, Taira Maekawa
  
• Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib;　2019/02
  ANNOUNCEMENT INFO.;　J Pharm Anal, 9, 1, 49-54
  AUTHOR;　Rintaro Sogawa, Tetsuya Saita, Yuta Yamamoto, Sakiko Kimura, Yutaka Narisawa, Shinya Kimura, Masashi Shin
  
• Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma;　2019/02
  ANNOUNCEMENT INFO.;　Ann Hematol, 98, 2, 465-471
  AUTHOR;　Hiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eisaburo Sueoka, Shinya Kimura
  
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method. ;　2018
  ANNOUNCEMENT INFO.;　Int J Hematol. , 108, 4, 416-422
  AUTHOR;　*Itamura H, Ide M, Sato A, Sueoka-Aragane N, Sueoka E, Nishida A, Masunari T, Aoki S, Takizawa J, Suzumiya J, Kimura S
  
• Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.;　2018
  ANNOUNCEMENT INFO.;　Anticancer Res. , 38, 6, 3559-3566
  AUTHOR;　Komiya K, Nakashima C, Nakamura T, Hirakawa H, Abe T, Ogusu S, Takahashi K, Takeda Y, Egashira Y, Kimura S, Sueoka-Aragane N
  
• Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma. ;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 47, 28547-28560
  AUTHOR;　Maeda A, Nishida Y, Weetall M, Cao L, Branstrom A, Ishizawa J, Nii T, SchoberWD, Abe Y, Matsue K, Yoshimura M, Kimura S, Kojima K.
  
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018
  ANNOUNCEMENT INFO.;　PLoS One. , 13, 12, e0209384
  AUTHOR;　Nakamura T, Nakashima C, Komiya K, Kitera K, Hirai M, Kimura S, Sueoka-Aragane N
  
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 38, 25181?25192
  AUTHOR;　Nakashima C, Sato A, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Final 3-year results of the Dasatinib Discontinuation Trial in Patients with Chronic Myeloid Leukemia who received dasatinib as a second line treatment;　2018
  ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk. , 18, 5, 353-360.e1
  AUTHOR;　*Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan.
  
• Prognostic impact of Acute myeloid leukemia with low allelic ratio FLT3-ITD and NPM1 mutation.;　2018
  ANNOUNCEMENT INFO.;　Blood Adv. , 2, 20, 2744-2754
  AUTHOR;　Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K
  
• Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia;　2018
  ANNOUNCEMENT INFO.;　Int J Clin Oncol. , 23, 5, 974-979
  AUTHOR;　Sogawa R, Kimura S, Yakabe R, Mizokami Y, Tasaki M, Sueoka-Aragane N, Narisawa Y, Kimura S.
  
• Investigation of Appropriate Pre-analytical Procedure for Circulating Free DNA from Liquid Biopsy.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 61, 31904-31914
  AUTHOR;　○Sato A, Nakashima C, Abe T, Kato J, Hiai M, Nakamura T, Komiya K, Kimura S, Sueoka E, Sueoka-Aragane N.
  
• Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis.;　2018
  ANNOUNCEMENT INFO.;　Respir Investig. , 56, 2, 166-172
  AUTHOR;　*Tashiro H, Takahashi K, Kusaba K, Tanaka M, Komiya K, Nakamura T, Aoki Y, Kimura S, Sueoka-Aragane N
  
• Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML.;　2018
  ANNOUNCEMENT INFO.;　Cancer Immunol Res. , 6, 6, 745-754
  AUTHOR;　Ureshino H, Shindo T, Kojma H, Kusunoki Y, Miyazaki Y, Tanaka H, Saji H, Kawaguchi A, Kimura S
  
• Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group.;　2018
  ANNOUNCEMENT INFO.;　Intern Med. , 57, 1, 17-23
  AUTHOR;　Iriyama N, Ohashi K, Hashino S, Kimura S, Nakaseko C, Takano H, Uchiyama M, Morita S, Sakamoto J, Sakamaki H, Inokuchi K
  
• Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, _Kimura S_.;　2017/12
  ANNOUNCEMENT INFO.;　*/Onnncoimmunology/*, 2017 Dec 11;7(3):e1405204.
  AUTHOR;　Deep sequencing of the Tcell receptor visualizes reconstitution of　T cell immunity in mogamulizumab-treated adult T cell leukemia.
  
• Newly designed silica-containing redox nanoparticles for oral delivery of novel Topoisomerase II catalytic inhibitor for treating colon cancer.;　2017/10
  ANNOUNCEMENT INFO.;　*/Advanced Healthcare Materials/*,2017 Oct;6(20). doi: 10.1002/adhm.201700428
  AUTHOR;　Vong LB, _Kimura S_, Nagasaki Y.
  
• Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report.;　2017
  ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 43
  AUTHOR;　Hirakawa H, Nakashima C, Nakamura T, Masuda M, Funakoshi T, Nakagawa S, Horimatsu T, Matsubara K, Muto M, Kimura S, Sueoka-Aragane N
  
• Elderly patients with chronic myeloid leukemia benefit from a dasatinib dose as low as 20 mg.;　2017
  ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk. , 17, 6, 370-374
  AUTHOR;　Itamura H, Kubota Y, Shindo T, Ando T, Kojima K, Kimura S
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.;　2017
  ANNOUNCEMENT INFO.;　Lung Cancer. , 110, 35-41
  AUTHOR;　Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Peculiar cold-induced leukoagglutination in Mycoplasma pneumoniae pneumonia.;　2017
  ANNOUNCEMENT INFO.;　Turk J Haematol. , 34, 4, 354-355
  AUTHOR;　Kubota Y, Hirakawa Y, Wakayama K, Kimura S
  
• Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.;　2017
  ANNOUNCEMENT INFO.;　Med Oncol. , 34, 12, 195
  AUTHOR;　＊Miyahara T, Sueoka-Aragane N, Iwanaga K, Ureshino N, Komiya K, Nakamura T, Nakashima C, Abe T, Matsunaga H, Kimura S.
  
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.;　2017
  ANNOUNCEMENT INFO.;　Oncol Lett. , 13, 6, 4939-4946
  AUTHOR;　Nakamura T, Watanabe N, Sato A, Komiya K, Umeguchi H, Hosomi T, Hirai M, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance.;　2017
  ANNOUNCEMENT INFO.;　Sci Rep. , 7, 1, 12885
  AUTHOR;　Nishida Y, Kimura S, Mizobe H, Yamamichi J, Kojima K, Kawaguchi A, Fujisawa M, Matsue K
  
• Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia ;　2017
  ANNOUNCEMENT INFO.;　Oncoimmunology. , 7, 3, e1405204
  AUTHOR;　Takero Shindo, Kazutaka Kitaura, Hiroshi Ureshino, Kazuharu Kamachi, Masaharu Miyahara, Kazuko Doi, Tatsuro Watanabe, Eisaburo Sueoka, Tadasu Shin-I, Ryuji Suzuki and Shinya Kimura
  
• Thin-section CT findings of multicentric Castleman disease changing over 10 years.;　2017
  ANNOUNCEMENT INFO.;　J Thorac Imaging. , 32, 6, W81-W83
  AUTHOR;　Tashiro H, Egashira R, Takahashi K, Fukui S, Kimura S, Nakazono T, Nojiri J, Fukuoka J, Irie H, Sueoka-Aragane N.
  
• Pre-existing chronic interstitial pneumonia is poor prognostic factor of Goodpasture's syndrome: a case and review of the literature;　2017
  ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 102
  AUTHOR;　Tashiro H, Takahashi K, Ikeda Y, Uchiumi S, Fukuda M, Miyazono M, Kimura S, Sueoka-Aragane N.
  
• Saturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat Diet.;　2017
  ANNOUNCEMENT INFO.;　Inflammation. , 40, 3, 1072-1086
  AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
  
• Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease;　2017
  ANNOUNCEMENT INFO.;　J Thorac Dis., 9, 2, 303-309
  AUTHOR;　Tashiro H, Takahashi K, Tanaka M, Komiya K, Nakamura T, Kimura S, Tada Y, Sueoka-Aragane N
  
• The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells;　2017
  ANNOUNCEMENT INFO.;　Blood Cancer J., 7, 2, e527
  AUTHOR;　Y Nishida, A Maeda, MJ Kim, L Cao, Y Kubota, J Ishizawa, A AlRawi, Y Kato, A Iwama, M Fujisawa, K Matsue, M Weetall, M Dumble, M Andreeff, TW Davis, A Branstrom, S Kimura, K Kojima
  
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients;　2017
  ANNOUNCEMENT INFO.;　Pathol Oncol Res., 23, 1, 181-188
  AUTHOR;　Ide M, Koba K, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E
  
• Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients;　2017
  ANNOUNCEMENT INFO.;　Pathol Oncol Res., 23, 4, 737-744
  AUTHOR;　Hosoya K, Matsusaka S, Kashiwada T, Suzuki K, Ureshino N, Sato A, Miki Y, Kitera K, Hirai M, Hatake K, Kimura S, Sueoka-Aragane N
  
• Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia.;　2016
  ANNOUNCEMENT INFO.;　Cancer Immunol Res., 4, 8, 644-9
  AUTHOR;　Ureshino H, Shindo T, Nishikawa H, Watanabe N, Watanabe E, Satoh N, Kitaura K, Kitamura H, Doi K, Nagase K, Kimura H, Sakurai R, Baba R, Kurogi K, Samukawa M, Kusunoki S, Miyahara M, Suzuki R, Sakaguchi S, Kimura S.
  
• Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model.;　2016
  ANNOUNCEMENT INFO.;　PLoS One., 11, 6, e0157571
  AUTHOR;　Tashiro H, Takahashi K, Hayashi S, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
  
• Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2016
  ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7
  AUTHOR;　Sueoka-Aragane N, Katakami N, Miyako M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S.
  
• Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations.;　2016
  ANNOUNCEMENT INFO.;　Leuk Res., 40, 68-76
  AUTHOR;　＊Okabe M, Yamaguchi H, Usuki K, Kobayashi Y, Kawada E, Kuroda J, Kimura S, Tajika K, Gomi S, Arima N, Mori S, Ishida Y, Koizumi M, Ito Y, Wakita S, Araua K, Kitano T, Kosaka F, Dan K, Inokuchi K.
  
• Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.;　2016
  ANNOUNCEMENT INFO.;　Mol Cancer Ther., 15, 1, 94-105
  AUTHOR;　＊Nemoto A, Saida D, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, SatoY, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K. Inukai T.
  
• Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.;　2016
  ANNOUNCEMENT INFO.;　Leuk Res., 51, 11-18
  AUTHOR;　＊Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Aoki M, Okada H, Yanada M, Ohyashiki K, Taniwaki M.
  
• The combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells.;　2016
  ANNOUNCEMENT INFO.;　Cancer Sci., 107, 7, 1029-38
  AUTHOR;　＊Matsuda Y, Yamauchi T, Hosono N, Uzui K, Negoro E, Morinaga K, Nishi R, Yoshida A, Kimura S, Maekawa T. Ueda T.
  
• Rapid sensitive analysis of IDH-1 mutation in low-grade gliomas by automated genetic typing involving a quenching probe.;　2016
  ANNOUNCEMENT INFO.;　Cancer Invest., 34, 1, 12-5
  AUTHOR;　＊Kurimoto M, Suzuki H, Aoki K, Ohka F, Kondo G, Motomura K, Iijima K, Yamamichi A, Ranjit M, Wakabayashi T, Kimura S, Natsume A.
  
• SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer.;　2016
  ANNOUNCEMENT INFO.;　Onco Targets Ther., 9, 6663-6668
  AUTHOR;　Komiya K, Nakamura T, Sadamatsu H, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
  
• The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma.;　2016
  ANNOUNCEMENT INFO.;　Oncotarget., 7, 43, 69625-69637
  AUTHOR;　Kojima K, Maeda A, Yohimura M, Nishida Y, Kimura S
  
• The MEK Inhibitor Trametinib Separates Murine Graft-versus-Host Disease from Graft-versus-Tumor Effects.;　2016
  ANNOUNCEMENT INFO.;　JCI Insight., 1, 10, e86331
  AUTHOR;　Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S.
  
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin.;　2016
  ANNOUNCEMENT INFO.;　Anticancer Res., https://www.ncbi.nlm.nih.gov/labs/articles/26722032/, 36, 1, 95-102
  AUTHOR;　 Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E
  
• For Hanshin-Saga Collaborative Cancer Study Group. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2016
  ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7
  AUTHOR;　Sueoka-Aragane N, Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S
  
• 2-Hydroxypropyl-β-cyclodextrin Acts as a Novel Anticancer Agent.;　2015
  ANNOUNCEMENT INFO.;　PLoS One., 10, 11, e0141946
  AUTHOR;　Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S
  
• Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer.;　2015
  ANNOUNCEMENT INFO.;　Acta Radiol Open., 4, 12, 2058460115588103
  AUTHOR;　Sueoka-Aragane N, Kobayashi N, Bonnard E, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
  
• Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells.;　2015
  ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun., 463, 4, 650-5
  AUTHOR;　Ahihara E, Munaka T, Kimura S, Nakagawa S, Naakagawa Y, Kanai M, Hirai H, Abe H, Miida T, Yamato S, Shoji S, Maekawa T.
  
• Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia.;　2015
  ANNOUNCEMENT INFO.;　Int J Clin Oncol., 20, 6, 1203-10
  AUTHOR;　Hosoya K, Mochinaga S, Emoto A, Yokoo H, Tokushima H, Egoshi M, Sueoka-Aragane N, Kimura S
  
• Discontinuation of dasatinib in chronic myeloid leukaemia patients who have maintained deep molecular response for more than 1 year: the prospective, multicentre Dasatinib Discontinuation (DADI) Trial.;　2015
  ANNOUNCEMENT INFO.;　Lancet Haematol., 2, 12, e528-35
  AUTHOR;　Imagawa J, Tanaka H, Okada M, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Morita S, Sakamoto J, Kimura S
  
• Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity;　2015
  ANNOUNCEMENT INFO.;　Biochem Biophys Res Commun., 457, 3, 288-94
  AUTHOR;　Matsuda K, Hattori S, Kariya R, Komizu Y, Kudo E, Goto H, Taura M, Ueoka R, Kimura S, Okada S.
  
• Preclinical activity of the novel BMI-1 inhibitor PTC-209 in acute myeloid leukemia: implications for leukemia therapy.;　2015
  ANNOUNCEMENT INFO.;　Cancer Sci., 106, 12, 1705-13
  AUTHOR;　Nishida Y, Maeda A, Chachad D, Ishizawa J, Yi Hua Q, Kornblau SM, Kimura S, Andreeff M, Kojima K
  
• Volume-based response evaluations with consensual lesion selection using cloud solutions (SaaS) in clinical trials: a pilot study;　2015
  ANNOUNCEMENT INFO.;　Acad Radiol., 22, 2, 217-25
  AUTHOR;　Oubel E, Bonnard E, Sueoka-Aragane N, Kobayashi N, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
  
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2015
  ANNOUNCEMENT INFO.;　Oncol Rep., 33, 1, 391-6
  AUTHOR;　Umeguchi H, Sueoka-Aragane N, Kobayashi N, Nakamura T, Sato A, Takeda Y, Hayashi S, Sueoka E, Kimura S.
  
• Comparative study of the anti-leukemic effects of imatinib mesylate, GlivecTM tablet and its generic formulation, OHK9511;　2015
  ANNOUNCEMENT INFO.;　Biol Pharm Bull., 38, 3, 411-6
  AUTHOR;　Yokoo M, Kubota Y, Tabe Y, Kimura S
  
• A novel frameshift mutation in exon 4 causes deficiency of high molecular weight kininogen;　2014
  ANNOUNCEMENT INFO.;　Intern Med. , 53, 3, 253-7
  AUTHOR;　Fukushima N, Itamura H, Wada H, Ikejiri M, Igarashi Y, Sano M, Komiyama Y, Icinohe T, Kimura S
  
• Small lymphocytic lymphoma presenting as bulky renal incidentaloma.;　2014
  ANNOUNCEMENT INFO.;　Int J Hematol. , 100, 2, 107-8
  AUTHOR;　Kamachi K, Kojima K, Nishijima A, Takeshita M, Ando T, Kimura S
  
• 2 Adrenergic Agonist Attenuates HDM-induced Allergic Airway Inflammation through Dendritic Cells.;　2014
  ANNOUNCEMENT INFO.;　BMC Immunol. , 15, 1, 39
  AUTHOR;　Kato G, Tahakashi K, Kurata K, Shirai H, Kimura S, Hayashi S.
  
• Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia.;　2014
  ANNOUNCEMENT INFO.;　Br J Haematol. , 166, 1, 2
  AUTHOR;　Kitamura H, Ando T, Kojima K, Komiya K, Sueoka-Aragane N, Kimura S.
  
• Bilateral renal infiltration as the initial presentation of multiple myeloma.;　2014
  ANNOUNCEMENT INFO.;　Br J Haematol. , 167, 1, 2
  AUTHOR;　Kubota Y, Matsuzaki M, Kimura S
  
• Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: A potential treatment for BCR-ABL positive leukemia;　2014
  ANNOUNCEMENT INFO.;　PLoS One. , 9, 2, e89080
  AUTHOR;　Okabe S, Tauchi T, Kimura S, Maekawa T, Ohyashiki K,
  
• Ohyashiki K. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL–positive leukemia cells involves the ABL kinase domain mutation.;　2014
  ANNOUNCEMENT INFO.;　Cancer Biol Ther. , 15, 2, 207-15
  AUTHOR;　Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T
  
• Mogamulizumab treatment in a hemodialysis patient with adult T-cell leukemia/lymphoma.;　2014
  ANNOUNCEMENT INFO.;　Turk J Haematol. , 31, 4, 424-425
  AUTHOR;　Yoshihara M, Kubota Y, Fukuda M, Kishi T, Ikeda Y, Kimura S.
  
• Induction of p53 transcription and apoptosis by Exportin-1 (XPO1) inhibition in mantle cell lymphoma.;　2014
  ANNOUNCEMENT INFO.;　Cancer Sci. , 105, 7, 795-801
  AUTHOR;　Yoshimura M, Ishizawa J, Dilip A, Ruvolo V, Quintas-Cardama A, McDonnel TJ, Neelapu SS, Kwak LW, Shachem S, Kauffman M, Yokoo M, Kimura S, Andreeff M, Kojima K.
  
• ABL tyrosine kinase inhibitor–induced pulmonary alveolar proteinosis in chronic myeloid leukemia.;　2014
  ANNOUNCEMENT INFO.;　Int J Hematol. , 100, 6, 611-4
  AUTHOR;　Yoshimura M, Kojima K, Tomimasu R, Fukushima N, Hayashi S, Sueoka E, Kimura S.
  
• Correlation between plasma DNA and tumor status in an animal model. ;　2014
  ANNOUNCEMENT INFO.;　PLoS One., 9, 12, e111881
  AUTHOR;　Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, Sueoka E, Kimura S
  
• Therapeutic management in cardiac lymphoma.;　2014
  ANNOUNCEMENT INFO.;　Leuk Lymphoma., 55, 5, 1215-1217
  AUTHOR;　Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S
  
• Neuroprotective efficacy of a new brain-penetrating c-Abl inhibitor in a murine Parkinson's disease model.;　2013
  ANNOUNCEMENT INFO.;　PLoS One, doi: 10.1371/journal.pone.0065129, 8, 5, e65129
  AUTHOR;　Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W, Li S, Clark RA, Ali SF.
  
• Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells.;　2013
  ANNOUNCEMENT INFO.;　Cancer Cell Int, 13, 1, 32
  AUTHOR;　Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T, Ohyashiki K.
  
• Development of lymphoproliferative diseases by hypoxia inducible factor-1 is associated with prolonged lymphocyte survival.;　2013
  ANNOUNCEMENT INFO.;　PLOS One, 8, 4, e57833
  AUTHOR;　Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakamichi K, Tanimoto K.
  
• Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.;　2013
  ANNOUNCEMENT INFO.;　PLoS One., 8, 4, e57833
  AUTHOR;　○Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakachi K, Tanimoto K.
  
• Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy.;　2013
  ANNOUNCEMENT INFO.;　World J Surg Oncol, 11, 167
  AUTHOR;　Yakabe T, Kitahara K, Komiya K, Sueoka-Aragane N, Kimura S, Sugioka T, Noshiro H.
  
• Targeting the hedgehog signaling pathway in therapy-resistant BCR-ABL1 positive leukemia with ponatinib.;　2013
  ANNOUNCEMENT INFO.;　Clin Cancer Res, 19, 6, 1422-1432
  AUTHOR;　Katagiri S, Tauchi T, Okabe S, Minami Y, Kimura S, Maekawa T, Naoe T, Ohyashiki K.
  
• Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.;　2013
  ANNOUNCEMENT INFO.;　Biomark Insights. doi: 10.4137/BMI.S12537, 8, 97-105
  AUTHOR;　Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S and Hayashi S.
  
• Ever-advancing chronic myeloid leukemia treatment;　2013
  ANNOUNCEMENT INFO.;　Int J Clin Oncol., 19, 1, 3-9
  AUTHOR;　Kimura S, Ando T, Kojima K
  
• Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.;　2013
  ANNOUNCEMENT INFO.;　Bioorgan Med Chem Lett, 23, 3, 606-609
  AUTHOR;　Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, Hattori S, Kimura S, Okada S.
  
• Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.;　2013
  ANNOUNCEMENT INFO.;　Cancer Chemother Pharmacol., 71, 1, 175-182
  AUTHOR;　○Miyahara T, Mochinaga S, Kimura S, Aragane N, Yakabe T, Morita S, Okudaira K, Fujito H.
  
• β-2 microglobulin is unsuitable as an internal reference for the analysis of gene expression in human colorectal cancer;　2013
  ANNOUNCEMENT INFO.;　Biomed Rep, 1, 2, 193-196
  AUTHOR;　Nihon-Yanagi Y, Terai K, Murano T, Kawai T, Kimura S, Okazumi S
  
• An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C.;　2013
  ANNOUNCEMENT INFO.;　J Viral Hepat, 20, 4, e124-e126
  AUTHOR;　Takahashi H, Mizuta T, Oeda S, Isoda H, Nakashita S, Kawaguchi Y, Izumi N, Hirai M, Kurose K, Iwane S, Eguchi Y, Kimura S, Anzai K, Ozaki I
  
• Uncommon case of chronic myeloid leukemia with multiple myeloma.;　2010
  ANNOUNCEMENT INFO.;　Int J Hemmatol,, 91, 4, 699-704
  AUTHOR;　Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H.
  
• Phase I study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias post-imatinib resistance or intolerance.;　2010
  ANNOUNCEMENT INFO.;　Cancer, 116, 11, 2665-2672
  AUTHOR;　*Kantarjian H, le Coutre P, Cortes J, Pinilla-lbarz J, Nagler A, Hochhaus A, Kimura S, Ottmann O
  
• Targeting ATF-3 by Galectin-9 induces apoptosis and overcomes various types of treatment resistance in chronic myelogenous leukemia.;　2010
  ANNOUNCEMENT INFO.;　Mol Cancer Res,, 8, 7, 994-1001
  AUTHOR;　Kuroda J, Kobayashi T, Nagoshi H, Yamamoto M, Sasaki N, Taki T, Kimura S, Yamauchi A, Hirashima M, Taniwaki M
  
• Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in hypoxic environment.;　2010
  ANNOUNCEMENT INFO.;　Cell Death Diff, 17, 7, 1211-1220
  AUTHOR;　*Takeuchi M, Kimura S, Kuroda J, Ashihara E, Kawatani M, Osada H, Umezawa K, Yasui E, Imoto M, Tsuruo T, Yokota A, Tanaka R, Nagao R, Nakahara T, Fujiyama Y, Maekawa T
  
• Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia.;　2010
  ANNOUNCEMENT INFO.;　Int J Hematol,, 91, 1, 132-135
  AUTHOR;　Tanaka M, Fukushima N, Urata C, Yokoo M, Ide M, HIsatomi T, Tomimasu R, Sueoka E
  
• Primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type is associated with chronic inflammatory process;　2010
  ANNOUNCEMENT INFO.;　Open J Hematol, 1-5
  AUTHOR;　Tanaka M, Fukushima N, Yamasaki F, Ohshima K, Sueoka E, Kimura S
  
• Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.;　2010
  ANNOUNCEMENT INFO.;　Blood, 116, 2089-2095
  AUTHOR;　*Tanaka R, Squires MS, Kimura S, Yokota A, Nagao R, Yamauchi T, Takeuchi M, Yao H, Reule M, Smyth T, Lyon JF, Thompson NT, Ashihara E, Ottmann OG, Maekawa T
  
• A Fully Integrated and Automated Detection System for Single Nucleotide Polymorphisms of UGT1A1 and CYP2C19.;　2010
  ANNOUNCEMENT INFO.;　Oncol Res
  AUTHOR;　Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima N, Hayashi S, Sueoka E, Kimura S
  
• Osteoclasts are involved in the maintenance of dormant leukemic cells.;　2010
  ANNOUNCEMENT INFO.;　Leuk Res., 34, 793-799
  AUTHOR;　Yokota A, Kimura S, Tanaka R, Takeuchi M, Yao H, Sakai K, Nagao R, Kuroda J, Kamitsuji Y, Kawata E, Ashihara E, Maekawa T
  
• Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.;　2009
  ANNOUNCEMENT INFO.;　Ann Oncol.
  AUTHOR;　Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E
  
• Intravesical administration of gd T cells successfully prevents the growth of bladder cancer in the murine model.;　2009
  ANNOUNCEMENT INFO.;　Cancer Immunol Immun, 58, 493-502
  AUTHOR;　* Yuasa T, Sato K, Ashihara E, Takeuchi M, Maita S, Tsuchiya N, Habuchi T, Maekawa T, Kimura S*.
  

Material, Commentary, Editorials, Research Report, A Comprehensive Journal Articles

• A 45-Year-Old Woman With Unexplained Iron Deficiency Anemia and No Respiratory Symptoms;　2023/01
  ANNOUNCEMENT INFO.;　Chest, 163, 1, e7-e11
  AUTHOR;　Kuwahara Y, Tashiro H, Takahashi K, Kimura S, Sueoka-Aragane N
  
• Type II Cryoglobulinemic Membranoproliferative Glomerulonephritis Caused by Mucosa-associated Lymphoid Tissue Lymphoma;　2023
  ANNOUNCEMENT INFO.;　Intern Med, 62, 13, 1983-1988
  AUTHOR;　*Sugihara A, Ureshino H, Yamasaki M, Fukuda M, Yoshihara M, Nonaka E, Miyazaki M, Fujita M, Ishii K, Kamachi K, Sano H, Okamoto S, Itamura H, Yoshimura M, Katsuya H, Ando T, Aoki S, Ubara Y, Kimura S
  
• Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia ;　2022/12
  ANNOUNCEMENT INFO.;　Hematology, 27, 1, 1171-1175
  AUTHOR;　*Ureshino H, Kamachi K, Sano H, Okamoto S, Itamura H, Yoshimura M, Katsuya H, Ando T, Kimura S
  
• Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma ;　2022/07
  ANNOUNCEMENT INFO.;　Int Cancer Conf J, 11, 4, 298-301
  AUTHOR;　Nagaie T, Kamachi K, Kitamura H, Ureshino H, Akashi M, Nishimura K, Meiri H, Kimura S, Miyahara M
  
• CASE REPORT Immune dysregulation syndrome with CTLA4 mutation showing multiple central nervous system lesions;　2022/05
  ANNOUNCEMENT INFO.;　Clinical and experimental neuroimmunology, 13, 2, 116-120
  AUTHOR;　○Makoto Eriguchi, Hiroo Katsuya, Keisuke Kidoguchi, Hiroshi Ureshino, Nishi Masanori, Masashi Nishihara, Motoshi Sonoda, Masataka Ishimura, Shinya Kimura, Hideo Hara
  
• Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia ;　2022/05
  ANNOUNCEMENT INFO.;　EJHaem, 3, 3, 1062-1063
  AUTHOR;　*Ayano Sugihara, Hiroo Katsuya, Hiroshi Ureshino, Shinichi Kido, Shinya Kimura
  
• Non-valvular Infective Endocarditis Caused by Sarocladium kiliense in an Immunocompromised Patient with Aplastic Anemia;　2022/04
  ANNOUNCEMENT INFO.;　Intern Med, 61, 8, 1279-1283
  AUTHOR;　Kitamura H, Kubota Y, Tomimasu R, Akashi M, Mori T, Mine Y, Ando J, Yamagata Murayama S, Kimura S, Miyahara M
  
• Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia;　2022/03
  ANNOUNCEMENT INFO.;　Cureus, 14, 3, e23688
  AUTHOR;　*Kyosuke Yamaguchi, Yasushi Kubota, Hiroo Katsuya, Toshihiko Ando, Shinya Kimura
  
• A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction ;　2021/12
  ANNOUNCEMENT INFO.;　Chest, 160, 6, e623-e628
  AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Tetsuro Haraguchi, Kazuki Jinnouchi, Shinya Kimura, Naoko Sueoka-Aragane
  
• Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma;　2021/11
  ANNOUNCEMENT INFO.;　eJHaem, 2, 4, 875–876
  AUTHOR;　Fujita M, Ureshino H, Kimura S
  
• Serial evaluation of the pharmacokinetics of ponatinib in patients with CML and Ph + ALL ;　2021/10
  ANNOUNCEMENT INFO.;　Int J Hematol, 114, 4, 509-516
  AUTHOR;　*Noriaki Kawano, Shinya Kimura, Masatomo Miura, Taro Tochigi, Takashi Nakaike, Kiyoshi Yamashita, Koichi Mashiba, Ikuo Kikuchi, Naoto Takahashi
  
• Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman ;　2021/09
  ANNOUNCEMENT INFO.;　Cureus, 13, 9, e17942
  AUTHOR;　Mai Fujita, Hiroshi Ureshino, Ayano Sugihara, Atsujiro Nishioka, Shinya Kimura
  
• Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute ;　2021/08
  ANNOUNCEMENT INFO.;　Int J Hematol, 114, 2, 199-204
  AUTHOR;　*Keisuke Kidoguchi, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Hiroo Katsuya, Yasushi Kubota, Toshihiko Ando, Masatomo Miura, Naoto Takahashi, Shinya Kimura
  
• Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma ;　2021/07
  ANNOUNCEMENT INFO.;　Cytometry B Clin Cytom, 100, 4, 454-456
  AUTHOR;　○Akihisa Umino, Yasushi Kubota, Miho Honda-Yoshigai, Tomomi Okazaki, Yurie Yoshihara, Kazuo Wakayama, Seiji Kawasaki, Kana Kusaba, Shinya Kimura, Eisaburo Sueoka
  
• Idiopathic eosinophilic pleurisy: A practical diagnostic approach ;　2021/05
  ANNOUNCEMENT INFO.;　Respir Med Case Rep, 33, 101430
  AUTHOR;　*Tetsuro Haraguchi, Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Naofumi Miyahara, Masafumi Hiratsuka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan;　2021/04
  ANNOUNCEMENT INFO.;　Intern Med, 60, 8, 1251-1255
  AUTHOR;　○Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Natsuko Komiya, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
  
• Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer ;　2021/03
  ANNOUNCEMENT INFO.;　Case Rep Oncol, 14, 1, 599-603
  AUTHOR;　○Natsuko Komiya, Koichiro Takahashi, Go Kato, Mio Kubota, Hiroki Tashiro, Chiho Nakashima, Tomomi Nakamura, Kentaro Iwanaga, Shinya Kimura, Naoko Sueoka-Aragane
  
• Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia;　2021/02
  ANNOUNCEMENT INFO.;　Turk J Haematol, 38, 1, 83-85
  AUTHOR;　*Keisuke Kidoguchi, Yasushi Kubato, Yuki Nishimura, Haruna Kizuka-Sano, Shinya Kimura
  
• Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis;　2021/01
  ANNOUNCEMENT INFO.;　Allergol Int, 70, 1, 145-147
  AUTHOR;　○Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
  
• Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome ;　2021
  ANNOUNCEMENT INFO.;　Intern Med, 60, 10, 1601-1605
  AUTHOR;　*Keisuke Kidoguchi, Yasushi Kubota, Shun Fujimoto, Yasuhisa Sakata, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Hiroshi Ureshino, Hiroo Katsuya, Toshihiko Ando, Motohiro Esaki, Shinya Kimura
  
• A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation;　2020/10
  ANNOUNCEMENT INFO.;　Ann Hematol, 99, 10, 2449-2451
  AUTHOR;　Hiroo Katsuya, Haruna Kizuka-Sano, Masako Yokoo, Keisuke Kidoguchi, Kyosuke Yamaguchi, Atsujiro Nishioka, Hiroshi Ureshino, Yasushi Kubota, Toshihiko Ando, Shinji Naito, Koichi Ohshima, Shinya Kimura
  
• Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report;　2020/10
  ANNOUNCEMENT INFO.;　Tohoku J Exp Med, 252, 2, 153-157
  AUTHOR;　Keisuke Kidoguchi, Hiroo Katsuya, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Ayako Nagata, Shuichi Rikitake, Kanako Aikawa, Shinji Naito, Shigehisa Aoki, Yasushi Kubota, Toshihiko Ando, Shinya Kimura
  
• Development of acquired hemophilia A after treatment of bronchial asthma with benralizumab;　2020/10
  ANNOUNCEMENT INFO.;　Indian J Hematol Blood Transfus
  AUTHOR;　Kitamura H, Kubota Y, Tomimasu R, Hirakawa H, Inoue H, Umeguchi H, Yoshida M, Akahoshi H, Tsuruda S, Ide R, Kimura S, Miyahara M
  
• Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor;　2020/08
  ANNOUNCEMENT INFO.;　Int J Hematol, 112, 2, 249-253
  AUTHOR;　Toshihiko Ando, Haruna Sano, Masako Yokoo, Kana Kusaba, Keisuke Kidoguchi, Kyosuke Yamaguchi, Hiroo Katsuya, Satoshi Yoshihara, Yasushi Kubota, Kensuke Kojima, Shinya Kimura
  
• A patient with antibody against low-frequency red blood cell antigen Co^b;　2020/07
  ANNOUNCEMENT INFO.;　Japanese Journal of Medical Technology, 69, 3, 445 - 450
  AUTHOR;　○Mami NAKAO, Marie YAMADA, Naotomo YAMADA, Seiji KAWASAKI, Hideaki NAKAMURA, Yasushi KUBOTA, Shinya KIMURA, Eizaburo SUEOKA
  
• Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy;　2020/06
  ANNOUNCEMENT INFO.;　Int J Hematol, 111, 6, 897-902
  AUTHOR;　Hiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura
  
• Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation;　2020/05
  ANNOUNCEMENT INFO.;　Int J Hematol, 111, 5, 733-738
  AUTHOR;　Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Oshima, Shinya Kimura
  
• Severe infusion reaction, anti-rituximab antibodies and lymphoma.;　2020/04
  ANNOUNCEMENT INFO.;　QJM, 113, 4, 273-274
  AUTHOR;　Kidoguchi K, Kubota Y, Kusaba K, Kizuka-Sano H, Yamaguchi K, Nishioka A, Yokoo M, Ando T, Kojima K, Kimura S.
  
• Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.;　2020/02
  ANNOUNCEMENT INFO.;　Ann Hematol. , 99, 2, 389-390
  AUTHOR;　Yamaguchi K, Kubota Y, Kishimori C, Ohno H, Kidoguchi K, Kizuka-Sano H, Nishioka A, Katsuya H, Ando T, Kimura S.
  
• A Case of Superficial-Type Gastric Cancer with Metastatic Ovarian Cancer Diagnosed by Exploratory Laparotomy;　2020/01
  ANNOUNCEMENT INFO.;　Gan To Kagaku Ryoho, 47, 1, 159-161
  AUTHOR;　
  
• Aplastic anemia in a patient with Cronkhite-Canada syndrome;　2020
  ANNOUNCEMENT INFO.;　Intern Med, in press
  AUTHOR;　Kidoguchi K, Kubota Y, Fujimoto S, SakataY, Kizuka-Sano H, Yamaguchi K, Ureshino H, Katsuya H, Ando T, Esaki M, Kimura S
  
• Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases.;　2019/11
  ANNOUNCEMENT INFO.;　Respir Investig. , 57, 6, 611-614
  AUTHOR;　Hirakawa H, Tashiro H, Takahashi K, Tanaka M, Sadamatsu H, Kimura S, Sueoka-Aragane N.
  
• BCR-ABL1- and CBFB-MYH11- positive chronic myeloid leukemiapresenting with primary blast crisis and marrow fibrosis;　2019/10
  ANNOUNCEMENT INFO.;　Ann Hematol. , 98, 10, 2461-2462
  AUTHOR;　Kidoguchi K, Kojima K, Yokoo M, Kimura S.
  
• Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.;　2019/07
  ANNOUNCEMENT INFO.;　Intern Med. , 58, 14, 2073-2077
  AUTHOR;　Kamachi K, Kubota Y, Nagaie T, Yamaguchi K, Ogusu S, Kidoguchi K, Kusaba K, Kizuka-Sano H, Nishioka A, Yoshimura M, Yokoo M, Ando T, Kai K, Kojima K, Ohshima K, Sueoka E, Kimura S.
  
• Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenstrom macroglobulinemia essential in MYD88 L265P mutation-positive cases?;　2019/03
  ANNOUNCEMENT INFO.;　Int J Hematol. , 109, 3, 247-248
  AUTHOR;　Kidoguchi K, Kojima K, Seki R, Nagafuji K, Oshima K, Kimura S.
  
• Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.;　2019/02
  ANNOUNCEMENT INFO.;　Int J Hematol. , 109, 2, 221-227
  AUTHOR;　Kamachi K, Shindo T, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Oshima K, Kimura S
  
• Acute myeloid leukemia with t(19;21)(q13;q22) transformed from myelodysplastic syndrome with marked eosinophilia.;　2019
  ANNOUNCEMENT INFO.;　Ann Haematol, 98, 1, 221-222
  AUTHOR;　Kubota Y, Kamachi K, Wakayama K, Kitamura H, Yoshihara M, Hisatomi T, Fukushima N, Ichinohe T, Sueoka E, Kimura S
  
• Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide.;　2018
  ANNOUNCEMENT INFO.;　Leuk Lymphoma. , 59, 10, 2474-2477
  AUTHOR;　Ando T, Kojima K, Sano H, Kidoguchi K, Kusaba K, Yoshimura M, Yokoo M, Kubota Y, Nakamura H, Takase Y, Aishima S, Kimura S
  
• A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy.;　2018
  ANNOUNCEMENT INFO.;　Ann Transl Med. , 6, 23, 464
  AUTHOR;　Hirakawa H, Komiya K, Nakashima C, Ogusu S, Nakamura T, Tanaka M, Takahashi K, Egashira Y, Kai K, Kimura S. Sueoka-Aragane N
  
• Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: a rare tumor combination and a potential pitfall of cytodiagnosis;　2018
  ANNOUNCEMENT INFO.;　Cytopathology, 29, 4, 400-402
  AUTHOR;　○Kai K, Ryu Y, Kamachi K, Nishioka A, Kubota Y, Nakamura M, Kimura S, Sueoka E, Aishima S
  
• Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring 17p deletion.;　2018
  ANNOUNCEMENT INFO.;　Intern Med. , 57, 6, 855-860
  AUTHOR;　Kitamura H, Kubota Y, Yamaguchi K, Kamachi K, Nishioka A, Yokoo M, ShindoT, AndoT, Kojima K, Kimura S
  
• Primary effusion lymphoma-like lymphoma with a T cell phenotype;　2018
  ANNOUNCEMENT INFO.;　Ann Hematol, 97, 4, 717?718
  AUTHOR;　*Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefpr AK, Matsuishi E
  
• Three coexisting lymphomas in a single patient: Composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma.;　2018
  ANNOUNCEMENT INFO.;　Int J Hematol. , 107, 6, 703-708
  AUTHOR;　Nishioka A, Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Itamura H, Kubota Y, Kojima K, Ohshima K, Kimura S
  
• Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?;　2018
  ANNOUNCEMENT INFO.;　Intern Med. , 57, 24, 3637-3641
  AUTHOR;　Ogusu S, Takahashi K, Hirakawa H, Tanaka M, Komiya K, Nakamura T, Egashira R, Kai K, Takeda Y, Kimura S, Sueoka-Aragane N
  
• Sj?gren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis. ;　2018
  ANNOUNCEMENT INFO.;　Case Rep Rheumatol. , 2018, 7475242
  AUTHOR;　Takahashi K, Sadamatsu H, Ogusu S, Komiya K, Nakamura T, Kimura S, Sueoka-Aragane N
  
• Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.;　2018
  ANNOUNCEMENT INFO.;　Hematol Oncol. , 36, 1, 324-327
  AUTHOR;　Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S
  
• Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement;　2017
  ANNOUNCEMENT INFO.;　Intern Med. , 56, 18, 2431-2433
  AUTHOR;　Akutagawa T, Shindo T, Yamanouchi K, Hayakawa M, Ureshino H, Tsuruoka N, Sakata Y, Shimoda R, Noguchi R, Furukawa K, Morita S, Iwakiri R, Kimura S, Matsumoto M, Fujimoto K.
  
• Successful Autologous Hematopoietic Stem Cell Transplantation Followed by Bortezomib Maintenance in a Patient with Relapsed CD138-low Multiple Solitary Plasmacytomas Harboring a 17p Deletion.;　2017
  ANNOUNCEMENT INFO.;　Intern Med.
  AUTHOR;　Kitamura H, Kubota Y, Yamaguchi K, Kamachi K, Nishioka A, Yokoo M, Shindo T, Ando T, Kojima K, Kimura S.
  
• Primary effusion lymphoma-like lymphoma with a T cell phenotype;　2017
  ANNOUNCEMENT INFO.;　Ann Hematol.
  AUTHOR;　Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefor AK, Matsuishi E.
  
• Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma;　2017
  ANNOUNCEMENT INFO.;　Int J Hematol.
  AUTHOR;　Nishioka A, Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Itamura H, Kubota Y, Kojima K, Ohshima K, Kimura S.
  
• Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma;　2017
  ANNOUNCEMENT INFO.;　Hematol Oncol.
  AUTHOR;　Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S.
  
• 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10);　2017
  ANNOUNCEMENT INFO.;　Int J Hematol., 105, 5, 692-696
  AUTHOR;　Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S.
  
• Paraneoplastic sarcoidosis in multiple myeloma;　2017
  ANNOUNCEMENT INFO.;　Intern Med., 56, 15, 2049-2051
  AUTHOR;　Kusaba K, Kojima K, Naito S, Taba M, Kai K, Ureshino H, Nishida Y, Kimura S
  
• Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma;　2016
  ANNOUNCEMENT INFO.;　Intern Med., 55, 15, 2061-4
  AUTHOR;　Ureshino H, Nishioka A, Kojima K, Suzuki M, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
  
• Acute Megakaryoblastic Leukemia with Myelodysplasia-related Changes Associated with ATM Gene Deletion.;　2016
  ANNOUNCEMENT INFO.;　Intern Med., 55, 12, 1625-9
  AUTHOR;　Ureshino H, Tanabe M, Kurogi K, Miyahara M, Kimura S
  
• Subdural hematoma associated with dasatinib and intrathecal methotrexate treatment in Philadelphia chromosome-positive acute lymphoblastic leukemia.;　2016
  ANNOUNCEMENT INFO.;　Intern Med., 55, 18, 2703-6
  AUTHOR;　Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
  
• Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report.;　2016
  ANNOUNCEMENT INFO.;　J Med Case Rep., 10, 1, 113
  AUTHOR;　Tashiro H, Takahashi K, Nakamura T, Komiya K, Kimura S. Sueoka-Aragane N.
  
• Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature.;　2016
  ANNOUNCEMENT INFO.;　Case Rep Rheumatol., 2016, 1658126
  AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Uchida M, Kimura S, Sueoka-Aragane N
  
• Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia;　2016
  ANNOUNCEMENT INFO.;　Intern Med, 55, 8, 1025-1026
  AUTHOR;　Nishioka A, Kubota Y, Sueoka E, Kimura S.
  
• Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus.;　2016
  ANNOUNCEMENT INFO.;　Ann Hematol., 95, 4, 653-5
  AUTHOR;　Kubota Y, Ichinohe T, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Sueoka E, Kimura S.
  
• Domino-style cerebral bleeding in immune thrombocytopenic purpura.;　2016
  ANNOUNCEMENT INFO.;　JAMA Neurol., 73, 4, 474-5
  AUTHOR;　Kitamura H, Shindo T, Yakushiji Y, Yoshihara M, Eriguchi M, Kubota Y, Noguchi T, Kimura S.
  
• Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature.;　2016
  ANNOUNCEMENT INFO.;　Int J Clin Exp Pathol, 9, 7, 7680-7685
  AUTHOR;　Kitamura H, Kubota Y, Fukushima N, Ichinohe T, Hayasaka D, Kamachi K, Yoshihara M, Itamura H, Hisatomi T, Wakayama K, Sueoka E, Kimura S.
  
• Hairy cell leukemia with systemic lymphadenopathy: Detection of BRAF mutation in a lymph node specimen.;　2015
  ANNOUNCEMENT INFO.;　Intern Med., 54, 11, 1397-402
  AUTHOR;　Okada K, Kunitomi A, Sakai K, Muramushi H, Okamoto Y, Tsukamoto T, Sugiura H, Matsui H, Jo T, Ueda T, Onishi T, Takizawa J, Aoki S, Ide M, Kimura S
  
• A case of relapsing polychondritis successfully treated with combination of a glucocorticoid and cyclosporine.;　2015
  ANNOUNCEMENT INFO.;　Int J Clin Med, 6, 7, PP. 439-443
  AUTHOR;　Takahashi K, Inoue H, Sadamatsu H, Umeguchi H, Sueoka-Aragane N, Kimura S
  
• Rituximab-containing chemotherapy (R-CHOP)-induced Kaposi’s sarcoma in an HIV-negative patient with diffuse large B cell lymphoma.;　2015
  ANNOUNCEMENT INFO.;　Intern Med., 54, 24, 3205-8
  AUTHOR;　Ureshino H, Ando T, Kojima K, Itamura H, Jinnnai S, Doi Kazuko, Oshima K, Kurogi K, Miyahara M, Kimura S.
  
• Spontaneous regression of methotrexate related lymphoproliferative disorder with T cell large granular lymphocytosis.;　2015
  ANNOUNCEMENT INFO.;　Intern Med., 54, 17, 2235-9
  AUTHOR;　Ureshino H, Kadota C, Kurogi K, Miyahara M, Kimura S
  
• Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.;　2015
  ANNOUNCEMENT INFO.;　Int J Hematol., 102, 3, 379-82
  AUTHOR;　Ando T, Kojima K, Isoda H, Eguchi Y, Honda T, Ishigami M, Kimura S
  
• Coexistence of ALK- anaplastic large cell lymphoma and CD4+ T cell large granular lymphocytic leukemia.;　2015
  ANNOUNCEMENT INFO.;　Ann Hematol., 94, 3, 539-40
  AUTHOR;　Kamachi K, Fukushima N, Ando T, Sato K, Ohshima K, Yokoo M, Shindo T, Kubota Y, Kojima K, Kimura S
  

General Lectures

• CMLの行育薬;　2023/01
  ANNOUNCEMENT INFO.;　
  AUTHOR;　
  
• Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions;　2022/12
  ANNOUNCEMENT INFO.;　64th ASH®Annual Meeting and Exposition(Hybrid event), 2022,12,10-13(on-site+on-line)
  AUTHOR;　*Bryan Valcarcel, Haruhiko Sano, Hiroo Katsuya, Atae Utsunomiya, Maki Otsuka, Masaharu Miyahara, Yasushi Takamatsu, Kenji Ishitsuka, Shinya Kimura, Junji Suzumiya, Kazuo Tamura, Daniel J Enriquez, Denisse Castro, Brady E Beltran, Henry Idrobo, Camila Pe?a, Lorena Fiad, Juan Carlos Ramos, Luis Enrique Malpica Castillo
  
• THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA;　2022/06
  ANNOUNCEMENT INFO.;　EHA2022 Congress(Hybrid event), 2022, 6, 9-17(on-site+on-line), Vienna, Austria
  AUTHOR;　*Fujita M, Itamura H, Miyazaki M, Ishii K, Sugihara A, Sano H, Okamoto S, Yoshimura M, Katsuya H, Ureshino H, Ando T, Kimura S
  
• Biological significance of UCK2 in HTLV-1-infected cells in ATL leukemogenesis and acquired resistance to azacitidine;　2022/06
  ANNOUNCEMENT INFO.;　EHA2022 Congress(Hybrid event), 2022, 6, 9-17(on-site+on-line), Vienna, Austria
  AUTHOR;　○Tatsuro Watanabe, Yuta Yamamoto, Kazuharu Kamachi, Yuki Kurahashi, Nao Yoshida-Saka, Hiroshi Ureshino, Yuki Fukuda-Kurahashi, Hideaki Nakamura, Eisaburo Sueoka, Shinya Kimura
  
• P-1030.Biological significance of pyrimidine metabolism enzyme UCK2 of HTLV-1-infected cells in ATL leukemogenesis;　2022
  ANNOUNCEMENT INFO.;　The 81st Annual Meeting of the Japanese Cancer Association(), 2022, 9,29-10, 1(On-site/Live streaming), 2022, 9,27-10, 1,10,28-11,(On-demand), P3-2:HTLV-1
  AUTHOR;　○Tatsuro Watanabe, Hiroshi Ureshino, Hideaki Nakamura, Eisaburo Sueoka, Shinya Kimura
  
• E-1006.Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia;　2022
  ANNOUNCEMENT INFO.;　The 81st Annual Meeting of the Japanese Cancer Association(), 2022, 9,29-10, 1(On-site/Live streaming), 2022, 9,27-10, 1,10,28-11,(On-demand), E9-1:Origin and applications to diagnosis and therapy of epigenomic alterations
  AUTHOR;　*Hiroshi Ureshino, Tatsuro Watanabe, Shinya Kimura
  
• Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial;　2021/12
  ANNOUNCEMENT INFO.;　63rd ASH Annual Meeting and Exposition (Hybrid Event), 2021,12,11-14
  AUTHOR;　*Kumagai T, Murai K, Ureshino H, Tanaka H, Nishiwaki K, Wakita S, Inokuchi K, Fukushima T, Yoshida C, Mita M, Uoshima N, Kiguchi T, Aoki J, Kimura S, Karimata K, Usuki K, Shimono J, Chinen Y, Kuroda J, Matsuda Y, Kensuke Nakao, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto C, Takeoka T, Io K, Kondo T, Miura M, Minami Y, Ikezoe T, Imagawa J, Takamori A, Kawaguchi A, Sakamoto J, and Kimura S
  
• The development of oral demethylating agent, OR-2100, and its impact on chronic myeloid leukemia;　2021/12
  ANNOUNCEMENT INFO.;　The 25th JFCR-ISCC (Hybrid Meeting) , 2021,12, 8-9 (On Site and Zoom)
  AUTHOR;　Kamachi K, Ureshino H, Kawasoe K, Yamamoto Y, Kurahashi Y, Watanabe T, Kimura S
  
• DNMT1 inhibitor and TKI combination for deeper response and depleting stem cell self-renewal in CML;　2021/10
  ANNOUNCEMENT INFO.;　23rd Annual John Goldman E-Conference on Chronic Myeloid Leukemia: Biology and Therapy (Virtual Event), 2021,10, 7-10
  AUTHOR;　Kamachi K, Ureshino H, Yoshida N, Yamamoto Y, Kurahashi Y, Watanabe T, Okada S, Kimura S
  
• Tiotropium/olodaterol reduces sedentary behavior in patients with treatment-na?ve chronic obstructive pulmonary disease;　2021/05
  ANNOUNCEMENT INFO.;　ATS 2021 International Conference (Virtual), 2021, 5,14-19
  AUTHOR;　Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Hironori Sadamatsu, Masaru Uchida, Go Kato, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi , Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama
  
• DNMT1 Inhibitor and TKI Combination for Deeper Response and Depleting Stem Cell Self-renewal in CML;　2021
  ANNOUNCEMENT INFO.;　The 12th JSH International Symposium 2021 in kamakura (Hybrid event), 2021, 5, 14-15 (On-site and On-line), 2021, 5,31-2021, 6, 14 (on-demand)
  AUTHOR;　Kamachi K, Ureshino H, Yoshida N, Yamamoto Y, Kurahashi Y, Watanabe T, Okada S, Kimura S
  
• The clinical outcomes of nivolumab plus ipilimumab combined with platinum-based chemotherapy, single-center, retrospective analysis;　2021
  ANNOUNCEMENT INFO.;　APSR 2021-The 25th Congress of the Asian Pacific Society of Respirology (Hybrid event), 2021,11,20-21(On-site, Virtual Live), 2021,11,22-12,28(On-demand)
  AUTHOR;　Natsuko Komiya, Chiho Nakashima, Yuuki Kuwahara, Hironori Sadamatsu, Yuuki Kurihara, Hiroki Tashiro, Tomomi Nakamura, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane
  
• A NEW HYPOMETHYLATING AGENT, OR-2100, RESISTS DEGRADATION BY CYTIDINE DEAMINASE, LEADING TO FAVOURABLE ORAL ABSORBABILITY AND ANT-LEUKAEMIA EFFECTS;　2020/06
  ANNOUNCEMENT INFO.;　25th EHA Congress (Virtual Congress), 2020, 6,11-21
  AUTHOR;　Hiroshi Ureshino, Tatsuro Watanabe, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Kaoru Tohyama, Seiji Okada, Toshikazu Ushijima, Shinya Kimura
  
• HLA POLYMORPHISMS PREDICT TREATMENT-FREE REMISSION FOLLOWING TKI DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA;　2020/06
  ANNOUNCEMENT INFO.;　25th EHA Congress (Virtual Congress), 2020, 6,11-21
  AUTHOR;　Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroo Saji, Shinya Kimura
  
• The Non-Antibiotic Macrolide EM900 attenuates HDM-induced airway inflammation in Obese Asthma Model;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kurihara Y, Kato G, Uchida M, Kurata K, Noguchi Y, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• Clinical characteristics and biomarker for Japanese asthmatic patients with obesity;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Sinya Kimura, Naoko Sueoka-Aragane
  
• The presence and possible role of virus-host chimeric transcripts in adult T-cell leukemia-lymphoma.;　2019
  ANNOUNCEMENT INFO.;　ASH2019, 2019, 12, 7-10
  AUTHOR;　Katsuya H, Miyazato P, Islam S, Tan BJY, Inada Y, Matsuo M, Ueno T, Tokunaga M, Hata H, Yamagishi M, Fujisawa J, Watanabe T, Uchimaru K, Utsunomiya A, Kimura S, Satou Y.
  
• An effect of novel non-antibiotic macrolide EM900 in HDM-induced airway inflammation mice model;　2019
  ANNOUNCEMENT INFO.;　ATS2019, 2019, 5, 17-22
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Noguchi Y, ?mura S, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• Characteristics of circulating tumor DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18
  AUTHOR;　Abe T, Nakashima C, Sato A, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Evaluation of low level detection of major BCR-ABL1 mRNA in chronic myeloid leukemia (DOMEST additional study);　2018
  ANNOUNCEMENT INFO.;　23rd Congress of EHA, 2018, 6, 14-17
  AUTHOR;　Hiroaki Kitamura,Yoko Tabe, Koji Tsuchiya, Maiko Yuri, Shigeki Misawa, Takashi Horii, Akimichi Ohsaka, Shinya Kimura
  
• irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors;　2018
  ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Haruki Hirakawa, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane.
  
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018
  ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26
  AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N
  
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier?;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18
  AUTHOR;　Nakashima C, Abe T, Sato A, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Investigation of origin of circulating free DNA: Is EV the carrier? ;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018, 5, 31- 6,2
  AUTHOR;　Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
  
• An Effect of Clarthromycin Treatment in HDM-Induced Allergic Airway Inflammation in Mice;　2018
  ANNOUNCEMENT INFO.;　ATS 2018, 2018, 5, 18-23
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Uchida M, Kimura S, Sueoka-Aragane N.
  
• Characteristics of circulating free DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　
  
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier?;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　Chiho Nakashima, Tomonori Abe, Yohei Harada, Akemi Sato, Tomomi Nakamura, Kazutoshi Komiya, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Characteristics of cell free DNA in lung cancer patients.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Characteristics of cell free DNA in lung cancer patients.;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Naomi Watanabe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Allelic polymorphisms of KIR and HLA predict favorable responses to TKIs in CML patients. 19th Annual John Goldman Conference on Chronic Myeloid Leukemia: ;　2017
  ANNOUNCEMENT INFO.;　19th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, 2017,10,12-15
  AUTHOR;　Kimura S.
  
• Downregulation of BMI-1 by the small molecule PTC596 induces mitochondrial apoptosis in mantle cell lymphoma;　2017
  ANNOUNCEMENT INFO.;　59th ASH Annual Meeting & Exposition, 2017, 12, 9-12
  AUTHOR;　Kojima K, Maeda A, Okamoto A, Nishida Y, Liangl C, Weetall M, Branstrom A, Kimura S
  
• Correlation and problems of re-biopsy and liquid biopsy for detecting T790M mutation.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Momoko Hayase, Haruki Hirakawa, Shinsuke Ogusu, Tomonori Abe, Chiho Nakashima, Koichiro Takahashi, Yuji Takeda, Kimura S, Sueoka-Aragane N.
  
• Clarification of mechanisms of acquired resistance for afatinib using plasma samples.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER., 2017,10,15-18
  AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N.
  
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate.;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30
  AUTHOR;　Chiho Nakashima, Tomonori Abe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane
  
• Automatic Digital Quantification of Bone Marrow Myeloma Volume in Appendicular Skeletons ? Clinical Implications and Prognostic Significance;　2017
  ANNOUNCEMENT INFO.;　59th ASH Annual Meeting & Exposition, 2017, 12, 9-12
  AUTHOR;　Nishida Y, Kimura S, Mizobe H, Yamamichi J, Kojima K, Kawaguchi A, Fujisawa M, Matsue K
  
• Recruited lung macrophages contribute to progression of airway inflammation in obesity asthma mice model. ;　2017
  ANNOUNCEMENT INFO.;　American Thoracic Society 2017 International Conference, May 19-24, 2017, Washington, D.C.
  AUTHOR;　Hiroki Tashiro, Hironori Sadamatsu, Koichiro Takahashi, Go Kato, Shinya Kimura, Naoko Sueoka-Aragane.
  
• IMPACT OF KIR3DL1*00501 IN TYROSINE KINASE INHIBITOR-TREATED CML;　2017
  ANNOUNCEMENT INFO.;　22nd Congress of EHA, 2017, 6, 22-25
  AUTHOR;　Hiroshi Ureshino , Takero Shindo, Yasushi Kusunoki , Yuki Miyazaki , Hiroto Kojima , Hidenori Tanaka , Hiroh Saji , Atsushi Kawaguchi , Shinya Kimura
  
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016
  ANNOUNCEMENT INFO.;　The 65th Annual Meeting of Japanese Society of Allergology (English oral session), 2016.6.17-19
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Shinichiro Hayashi, Shinya Kimura, Naoko Sueoka-Aragane
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2016, 2016 April 16-20
  AUTHOR;　Watanabe-Kobayashi N, Sato A, Watanabe T, Sueoka E, Kimura S, Sueoka-Aragane N
  
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016
  ANNOUNCEMENT INFO.;　ATS International Conference 2016, 2016, May, 13-18
  AUTHOR;　H. Tashiro, K. Takahashi, G. Kato, S. Hayashi, S. Kimura, N. Sueoka-Aragane
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016
  ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016
  AUTHOR;　Naoko Sueoka-Aragane, Naomi Watanabe, Akemi Sato, Tatsuro Watanabe, Eisaburo Sueoka, Shinya Kimura
  
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model;　2016
  ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016
  AUTHOR;　Chiho Nakashima, Akemi Sato, Shinya Kimura, Naoko Aragane
  
• A retrospective analysis of the efficacy and safety of ALK inhibitors in ALK-positive lung cancer patients;　2016
  ANNOUNCEMENT INFO.;　IASLC 17th WORLD CONFERENCE ON LUNG CANCER, 2016.12.4-7
  AUTHOR;　Komiya K, Nakamura T, Kurihara Y, Hirakawa H, Sadamatsu H, Nakashima C, Umeguchi H, Takeda Y, Kimura S, Sueoka-Aragane N
  
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2015
  ANNOUNCEMENT INFO.;　The Japanese Society of Medical Oncology 2015 Annual Meeting, 2015.7.16-18
  AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
  
• Monocytes IL-33 contributes to HDM-induced allergic airway inflammation;　2015
  ANNOUNCEMENT INFO.;　American Thoracic Society 2015 International Conference in Denver, 2015, 5, 15-20
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Naoko Sueoka-Aragane, Shinya Kimura ,Shinichiro Hayashi
  
• The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects.;　2015
  ANNOUNCEMENT INFO.;　2015 BMT Tandem Meetings, 2015,2,11-15
  AUTHOR;　Itamura H, Shindo T, Tawara I, Kariya R, Okada S, Komanduri KV, Kimura S
  
• The MEK inhibitior Trametinib selectively suppresses Graft-versus-Host Disease (GVHD), while sparing Graft-versus-Tumor (GVT) effects.;　2015
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Itamura H, Shindo T, Kubota Y, Kimura S
  
• SPARC, a possible predictive marker to albumin-bound paclitaxel (nab-paclitaxel) in non-small cell lung cancer;　2015
  ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Hironori Sadamatsu, Chiho Nakashima, Koichiro Takahashi, Hitomi Umeguchi, Naomi Kobayashi, Akemi Sato, ○Yuji Takeda, Shinya Kimura, Naoko Sueoka-Aragane
  
• Potential predictive markers for re-challenge with first generation and second generation EGFR-TKI;　2015
  ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9
  AUTHOR;　Tomomi Nakamura, Akemi Sato, Naomi Kobayashi, Hitomi Umeguchi, Kazutoshi Komiya, Shinya Kimura, Naoko Aragane
  
• Clinical features and treatment outcomes of acute erythroid leukemia in the last decade;　2015
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Nishioka A, Kubota Y, Yamaguchi K, Kamachi K, Kitamura H, Yokoo M, Shindo T, Ando T, Kojima K, Sueoka E, Kimura S
  
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2014
  ANNOUNCEMENT INFO.;　73th Annual Meeting of the Japanese Cancer Association, 2014.9.25-27
  AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
  
• Volume-based response evaluations with consensual lesion selection using cloud solutions in clinical trials: a pilot study;　2014
  ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 – June 3, 2014
  AUTHOR;　Estanislao Oubel, Eric Bonnard, Sueoka-Aragane N, Kobayashi N, C.Charbonnier, Yamamichi J, Mizobe H, Kimura S
  
• Efficacy and toxicity of mogamulizumab for relapsed/refractory adult T-cell leukemia-lymphoma: a retrospective analysis in Saga prefecture, Japan;　2014
  ANNOUNCEMENT INFO.;　The 19th European Hematology Association Congress, June 12－15, 2014
  AUTHOR;　Kamachi K, Kubota Y, Ureshino H, Miyahara M, Yoshihara M, Kitamura H, Ide M, Shindo T, Ando T, Kojima K, Sueoka E, Kimura S
  
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent. ;　2014
  ANNOUNCEMENT INFO.;　The 19th European Hematology Association Congress, June 12－15, 2014
  AUTHOR;　Kubota Y, Yokoo M, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S
  
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2014
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2014, April 5-9, 2014
  AUTHOR;　Kobayashi N,Sueoka-Aragane N,Umeguchi H,Nakamura T,Sato A,Komiya K, Takeda Y,Hayashi S, Sueoka E, Kimura S
  
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer;　2014
  ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 – June 3, 2014
  AUTHOR;　Sueoka-Aragane N,Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K,Kimura S, Negoro S
  
• Non-invasive monitoring system for acquired resistance to EGFR-tyrosine kinase inhibitors using circulating plasma DNA;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Sueoka-Aragane N,Nakamura T,Sato A,Kobayashi N,Iwanaga K,Komiya K, Hosomi T, Hirai M,Sueoka E,Okada S,Kimura S
  
• Monitoring of EGFR T790M with plasma in lung cancer patients;　2014
  ANNOUNCEMENT INFO.;　ESMO 2014 Congress, September 26-30, 2014.
  AUTHOR;　Urata Y,Sueoka-Aragane N, Katakami N, Satouchi M,Yokota S, Aoe K, Iwanaga K, Otsuka K, KimuraS,Negoro S
  
• Ⅲ (EFM) patient with rare genotype expressing anti-E antibody after transfusion of platelet concentrates;　2014
  ANNOUNCEMENT INFO.;　AABB Annual Meeting 2014, October 25-28, 2014
  AUTHOR;　〇Yamada M, Yamada N, Kon N, Miyazaki T, Ohasi W, Sato S, Higasitani T, Kubota Y, Takamoto S, Kimura S, Sueoka E. A partial E
  
• Anti-proliferative effect of 2-hydroxypropyl-β-cyclodextrin against chronic myeloid leukemia;　2014
  ANNOUNCEMENT INFO.;　Saga and NUS joint meeting for CyD, 2014.3.28
  AUTHOR;　Yokoo M, Kubota Y, Kimura S
  
• Low-dose dasatinib treatment for elderly CML patients;　2014
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Itamura H, Kamachi K, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S
  
• Two cases of meningeal infiltration with adult T cell leukemia/lymphoma after mogamulizumab treatment;　2014
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Kamachi K, Yasushi Kubota Y, Nishioka A, Yamuguchi K, Kitamura H, Yokoo M, Shindo T, Ando T, Kojima K, Kimura S
  
• Three cases of hemodialysis patients with advanced gastric cancer treated with Paclitaxel and nab paclitaxel;　2014
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Kashiwada　T、Aragane　N、Kimura　S
  
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia;　2014
  ANNOUNCEMENT INFO.;　The 5th JSH International Symposium 2014, 2014,5,24-25
  AUTHOR;　Kitamura H,Ando T,Kojima K,Kamachi K,Yoshihara M,Shindo T,Kubota Y,Komiya K,Sueoka-Aragane N, Sueoka E, Kimura S
  
• Two cases of immune thrombocytopenic purpura with multiple cerebral microbleeds;　2014
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Kitamura H,Yoshihara M,Kamachi K,Eriguchi M, Noguchi T,Kubota Y,Shindo T,Ando T,Sueoka E,Kojima K,Kimura S
  
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors.;　2014
  ANNOUNCEMENT INFO.;　第73回日本癌学会学術集会総会, 2014.9.25-27
  AUTHOR;　Kobayashi N, Sueoka-Aragane N, Nakamura T, Sato A, Komiya K, Sueoka E, Kimura S
  
• SPARC, as a possible predictive marker for albumin-bound paclitaxel in non-small cell lung cancer;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Komiya K, Sueoka-Aragane N, Kobayashi N, Sato A, Nakamura T, Hayash S,Kimura S
  
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent.;　2014
  ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2
  AUTHOR;　Kubota Y, Yokoo M, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Tabe Y, Sueoka E, Arima H, Irie T, Kimura S
  
• Small lymphocytic lymphoma presenting as bulky renal incidentaloma;　2014
  ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2
  AUTHOR;　○Kusano S,Kamachi K, Kojima K, Kitamura H, Shindo T, Kubota Y, Ando T, Kimura S
  
• Correlation between plasma DNA and tumor status in an animal model on metastasis of lung cancer;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Sato A,Sueoka-Aragane N, Kobayashi N,Nagano Y,Sueoka E,Okada S,Kimura S
  
• Brainstem Encephalitis with anti-ganglioside antibody associated with mogamulizumab treatment;　2014
  ANNOUNCEMENT INFO.;　第76回日本血液学会学術集会, 2014.10.31-11.2
  AUTHOR;　Ureshino H, Shindo T, Miyahara M, Nishikawa H, Sakaguchi S, Samukawa M, Kusunoki S,Kimura S
  
• Induction of p53 Transcription and Apotosis by XPO1 Inhibition in Mantle Cell Lymphoma.;　2013
  ANNOUNCEMENT INFO.;　The 55th Annual Meeting of the American Society of Hematology, 2013.12.7-10
  AUTHOR;　Yoshimura M, Ishizawa J, Dilip A, Ruvolo V, Quintas-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shachem S, kauffman M, Tabe Y, Yokoo M, Kimura S, Andreeff M, Kojima K
  
• Establishment of animal model for metastasis of human lung cancers using NOJ/SCID mice.;　2013
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2013, April 6-10
  AUTHOR;　Naoko Aragane, Akemi Sato, Naomi Kobayashi, Masaru Ide, Eisaburo Sueoka, Seiji Okada, Shinya Kimura.
  
• Establishment of a rapid and automated detection system for BRAF mutations in malignant melanoma.;　2013
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2013, April 6-10, 2013
  AUTHOR;　Masaru Ide, Shinichi Koba, Yumi Nagano, Naoko Aragane-Sueoka, Akemi Sato, Takuya Inoue, Naomi Kobayashi, Noriyuki Misago, Yutaka Narisawa, Shinya Kimura, Eisaburo Sueoka.
  
• Non-invasive monitoring system using circulating plasma DNA;　2013
  ANNOUNCEMENT INFO.;　The 72th Annual Meeting of the Japanese Cancer Association, October 3-5
  AUTHOR;　Naoko Aragane, Tomomi Nakamura, Akemi Sato, Naomi Kobayashi, Kentaro Iwanaga, Kazutoshi Komiya, Toshiya Hosomi, Mitsuharu Hirai, Eisaburo Sueoka, Seiji Okada, Shinya Kimura.
  
• A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids;　2013
  ANNOUNCEMENT INFO.;　European Respiratory Society, International Congress 2013 in Barcelona, 2013. 9.7 - 11
  AUTHOR;　Koichiro Takahashi, Go Kato, Shinya Kimura and Shinichiro Hayashi
  
• Deferasirox in iron-overloaded patients with hematologic diseases at Saga University Hospital;　2013
  ANNOUNCEMENT INFO.;　
  AUTHOR;　○Abe O, Yoshihara M, Kubota Y, Sueoka E, Kamachi K, Kitamura H, Itamura H, Nishi M, Shindo T, Fukushima N, Hamasaki Y, Kimura S
  
• Therapeutic management in cardiac lymphoma;　2013
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Yoshihara M, Itamura H, Fukushima N, Kamach K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Ichinohe T, Kimura S
  

Review Articles

• Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphoma;　2023
  ANNOUNCEMENT INFO.;　, 15, 22, 5399-5412
  AUTHOR;　Katsuya H, Suzumiya J, Kimura S
  
• アカデミア創薬に向けて―臨床から;　2023
  ANNOUNCEMENT INFO.;　, 31, 1, 109-114
  AUTHOR;　
  
• Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia;　2020/12
  ANNOUNCEMENT INFO.;　Clin Lymphoma Myeloma Leuk, 20, 12, 785-790
  AUTHOR;　Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
  
• Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia;　2020/07
  ANNOUNCEMENT INFO.;　Immunol Med
  AUTHOR;　*Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura
  
• Role of cancer immunology in chronic myelogenous leukemia;　2020/01
  ANNOUNCEMENT INFO.;　Leuk Res, 88, 106273
  AUTHOR;　Hiroshi Ureshino, Takero Shindo, Shinya Kimura
  
• Development status of new therapeutic agents for CML;　2019/05
  ANNOUNCEMENT INFO.;　Hematology, 78, 5, 657 - 663
  AUTHOR;　Kimura Shinya
  
• Evaluation of CML therapy by tyrosine kinase inhibiters and possibility of stop them;　2019/01
  ANNOUNCEMENT INFO.;　, 268, 1, 67 - 71
  AUTHOR;　Kusaba Kana, KImura Shinya
  
• Epigenetic abnormalities as a therapeutic target in adult T-cell leukemia-lymphoma;　2019/01
  ANNOUNCEMENT INFO.;　Hematology, 78, 1, 117 - 121
  AUTHOR;　○Watanabe Tatsuro, Kimura Shinya
  
• The Current State of Therapeutic Development for Rare Cancers in Japan, and Proposals for Improvement.;　2018
  ANNOUNCEMENT INFO.;　Cancer Sci. , 109, 5, 1731-1737
  AUTHOR;　*Kawai A, Goto T, Shibata T, Tani K, MizutaniS, Nishikawa A, Shibata T, Matsumoto S, Nagata K, Narukawa M, Matsui S, Ando M, Toguchida J, Monden M, Heika T, Kimura S, Ueda R
  
• Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemia;　2016
  ANNOUNCEMENT INFO.;　Stem Cell Investig., http://sci.amegroups.com/article/view/11261/11838, 3, 36
  AUTHOR;　Kimura S.
  
• Ever-advancing chronic myeloid leukemia treatment;　2014
  ANNOUNCEMENT INFO.;　Int J Clin Oncol. , 19, 1, 3-9
  AUTHOR;　Kimura S, Ando T, Kojima K
  

Invited Lecture, Special Lecture

• どんどん進化する白血病治療;　2023/07
  ANNOUNCEMENT INFO.;　
  AUTHOR;　
  
• 全てのCML患者の治癒を目指して;　2023/06
  ANNOUNCEMENT INFO.;　
  AUTHOR;　
  
• Cutting edge therapeutic approaches in CML From Japan Perspective;　2021/04
  ANNOUNCEMENT INFO.;　ICKSH 2021(Virtual), 2021, 4, 1-3
  AUTHOR;　Kimura S
  
• ABL Tyrosine Kinase Inhibitors and Minimal Residual Disease Negativity during Treatment and Stop ;　2018
  ANNOUNCEMENT INFO.;　Anti-Cancer Treatment Japan, 2018, 5,18-19
  AUTHOR;　Kimura S
  
• Molecular target therapy and new technologies;　2016
  ANNOUNCEMENT INFO.;　8th International Workshop on Advanced Materials Science and Nanotechnology ( IWAMSN 2016), 2016.11.8-12
  AUTHOR;　Kimura S
  
• Exploring the Anti-tumor Mechanisms of Zoledronic acid.;　2010/09
  ANNOUNCEMENT INFO.;　Taiwan Breast Cancer Clinical and Basic Seminar.
  AUTHOR;　Kimura S
  
• Anticancer effects of bisphosphonates: Pre-clinical Outlook.;　2010/07
  ANNOUNCEMENT INFO.;　Breast cancer 18th Opinion Leader Summit,
  AUTHOR;　Kimura S.
  
• Role of TKIs in CML;　2010/06
  ANNOUNCEMENT INFO.;　KSH-JSH joint Meeting.
  AUTHOR;　Kimura S.
  
• Activity of the Multi-targeted Kinase Inhibitor, AT9283 on Imatinib-Resistant CML Models;　2009/09
  ANNOUNCEMENT INFO.;　ESH Eleventh International Conference on CML
  AUTHOR;　Kimura S, Tanaka R, Matthew S Squires3, Yokota A, Kirsty Mallett, Matthias Reule , Tomoko Smyth, Neil T Thompson, Nagao R, Yamauchi T, Ashihara E, John F Lyons, Maekawa T
  
• Lesson from CML, molecular targets in myeloid leukemias.;　2009/03
  ANNOUNCEMENT INFO.;　6th Korean Society of Hematology AML/MDS Working Party Symposium, 3rd Korean-Japan Joint Symposium on "Molecular Targets and AML/MDS Therapeutics
  AUTHOR;　Kimura S
  
• Exploring the antitumor mechanisms of bisphosphonates in clinic. Modulating the immune response. 　;　2009/01
  ANNOUNCEMENT INFO.;　ZENITH Meeting.
  AUTHOR;　Kimura S